{"content":"<li class=\"n-box-item date-title\" data-end=\"1536811199\" data-start=\"1536724800\" data-txt=\"Monday, December 23, 2019\">Wednesday, September 12, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3389877\" data-ts=\"1536790927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CZR\" target=\"_blank\">CZR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389877-report-vora-capital-builds-caesars-stake-to-push-for-sale-sharesplus-4_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Vora Capital builds Caesars stake to push for sale; shares +4.4%</a></h4><ul>   <li>Activist fund HG Vora Capital is quietly <a href=\"https://nypost.com/2018/09/12/activist-hedge-fund-secretly-built-stake-to-push-caesars-sale/\" target=\"_blank\">building up a stake</a> in order to push Caesars Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment'>CZR</a>) toward a sale of the company, the <i>New York Post</i> reports.</li>    <li><a href='https://seekingalpha.com/symbol/CZR' title='Caesars Entertainment'>CZR</a> has <font color='green'>jumped 4.4%</font> after hours, and <font color='green'>gained 3%</font> during the regular session today.</li>    <li>The hedge fund has amassed a 4.9% shareholding and joins in with growing shareholder discontent, and wants to see a sale of at least significant assets.</li>    <li>The report notes a belief that a lack of support of Mark Frissora (installed as CEO in 2015 by Apollo Global Management and TPG Capital) is keeping institutional investors from buying shares, weighing on the stock price.</li>    <li>Frissora's contract expires in February 2019; he had stepped down from Hertz Holdings in 2014 under pressure from Carl Icahn after that company reported accounting errors.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389877\" data-linked=\"Report: Vora Capital builds Caesars stake to push for sale; shares +4.4%\" data-tweet=\"$CZR - Report: Vora Capital builds Caesars stake to push for sale; shares +4.4% https://seekingalpha.com/news/3389877-report-vora-capital-builds-caesars-stake-to-push-for-sale-sharesplus-4_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3389877-report-vora-capital-builds-caesars-stake-to-push-for-sale-sharesplus-4_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389872\" data-ts=\"1536789034\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EC\" target=\"_blank\">EC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389872-talk-of-ecopetrol-sale-nixed-new-colombian-president\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Talk of Ecopetrol sale nixed by new Colombian president</a></h4><ul><li>Ecopetrol (NYSE:<a href='https://seekingalpha.com/symbol/EC' title='Ecopetrol S.A.'>EC</a>) <font color='red'>-2.4%</font> after-hours as Colombia&rsquo;s recently elected Pres. Duque <a href=\"https://www.ft.com/content/49aee624-b6cf-11e8-bbc3-ccd7de085ffe\" target=\"_blank\">categorically rules out a sale</a>, saying the state-owned company should remain &ldquo;a symbol of our country.\"</li><li>Some speculation pointed to Duque's market-friendly government possible selling its shares in EC, Colombia&rsquo;s biggest oil producer by far; the Colombian government owns more than 88% of the company.</li><li>EC produced 721K bbl/day in Q2, its highest quarterly output in nearly two years.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389872\" data-linked=\"Talk of Ecopetrol sale nixed by new Colombian president\" data-tweet=\"$EC - Talk of Ecopetrol sale nixed by new Colombian president https://seekingalpha.com/news/3389872-talk-of-ecopetrol-sale-nixed-new-colombian-president?source=tweet\" data-url=\"https://seekingalpha.com/news/3389872-talk-of-ecopetrol-sale-nixed-new-colombian-president\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389868\" data-ts=\"1536788132\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PI\" target=\"_blank\">PI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389868-after-hours-gainers-losers-09-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (09/12/2018)</a></h4><ul><li><b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/PI' title='Impinj, Inc.'>PI</a> <font color='green'>+33.9%</font>. <a href='https://seekingalpha.com/symbol/BXG' title='Bluegreen Vacations Corp.'>BXG</a> <font color='green'>+11.9%</font>. <a href='https://seekingalpha.com/symbol/TLRD' title='Tailored Brands, Inc'>TLRD</a> <font color='green'>+4.8%</font>. <a href='https://seekingalpha.com/symbol/BRFS' title='BRF-Brasil Foods S.A.'>BRFS</a> <font color='green'>+2.5%</font>. <a href='https://seekingalpha.com/symbol/GSKY' title='GreenSky'>GSKY</a>&nbsp;<font color='green'>+2.4%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/PVTL' title='Pivotal Software'>PVTL</a> <font color='red'>-21.8%</font>. <a href='https://seekingalpha.com/symbol/PGNX' title='Progenics Pharmaceuticals Inc.'>PGNX</a> <font color='red'>-17.7%</font>. <a href='https://seekingalpha.com/symbol/IGT' title='International Game Technology'>IGT</a> <font color='red'>-5.5%</font>. <a href='https://seekingalpha.com/symbol/SFUN' title='Fang Holdings Ltd. ADS'>SFUN</a> <font color='red'>-3.2%</font>. <a href='https://seekingalpha.com/symbol/MPWR' title='Monolithic Power Systems, Inc.'>MPWR</a> <font color='red'>-3.1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389868\" data-linked=\"After Hours Gainers / Losers (09/12/2018)\" data-tweet=\"$PI $PI $BXG - After Hours Gainers / Losers (09/12/2018) https://seekingalpha.com/news/3389868-after-hours-gainers-losers-09-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389868-after-hours-gainers-losers-09-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389853\" data-ts=\"1536786004\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLPG\" target=\"_blank\">GLPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389853-galapagos-launches-300m-ads-offering-shares-up-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Galapagos launches $300M ADS offering; shares up 1% after hours</a></h4><ul><li>Galapagos NV (NASDAQ:<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a>) <a href=\"https://seekingalpha.com/pr/17268471-galapagos-announces-launch-proposed-public-offering\" target=\"_blank\">readies </a>a $300M public offering of American Depositary Shares (ADSs). Price, volume and terms have yet to be announced.</li><li>Shares are up&nbsp;<font color='green'>1%&nbsp;</font>after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389853\" data-linked=\"Galapagos launches $300M ADS offering; shares up 1% after hours\" data-tweet=\"$GLPG - Galapagos launches $300M ADS offering; shares up 1% after hours https://seekingalpha.com/news/3389853-galapagos-launches-300m-ads-offering-shares-up-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3389853-galapagos-launches-300m-ads-offering-shares-up-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389851\" data-ts=\"1536785800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOMX\" target=\"_blank\">FOMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389851-foamix-pharma-readies-70m-stock-offering-shares-up-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Foamix Pharma readies $70M stock offering; shares up 1% after hours</a></h4><ul><li>Foamix Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/FOMX' title='Foamix Pharmaceuticals'>FOMX</a>) <a href=\"https://seekingalpha.com/pr/17268453-foamix-announces-proposed-follow-offering-ordinary-shares\" target=\"_blank\">launches </a>a $70M public offering of ordinary shares. Price, volume and terms have yet to be announced.</li><li>Shares are up&nbsp;<font color='green'>1%&nbsp;</font>after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389851\" data-linked=\"Foamix Pharma readies $70M stock offering; shares up 1% after hours\" data-tweet=\"$FOMX - Foamix Pharma readies $70M stock offering; shares up 1% after hours https://seekingalpha.com/news/3389851-foamix-pharma-readies-70m-stock-offering-shares-up-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3389851-foamix-pharma-readies-70m-stock-offering-shares-up-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389847\" data-ts=\"1536785525\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PI\" target=\"_blank\">PI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389847-impinjplus-28-on-q2-beats-upside-guide-audit-committee-closes-investigation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Impinj +28% on Q2 beats, upside guide; Audit Committee closes investigation</a></h4><ul><li>        Impinj (NASDAQ:<a href='https://seekingalpha.com/symbol/PI' title='Impinj, Inc.'>PI</a>)&nbsp;<font color='green'>gains 27.8%</font>&nbsp;on Q2 results that beat EPS and revenue estimates with 16% Y/Y revenue drop. Upside Q3 guidance has revenue of $33M to $34M (consensus: $32.53M) and EPS of -$0.12 to -$0.17 (consensus: -$0.26).</li><li>               The Audit Committee and independent counsel conducting the previously announced internal investigation have concluded that there was no credible evidence supporting the former employee&rsquo;s complaint.&nbsp;</li><li>               Earnings call is scheduled for 8 AM Eastern tomorrow morning with a webcast available <a href=\"http://investor.impinj.com/phoenix.zhtml?c=246148&amp;p=irol-irhome\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17268451-impinj-reports-full-second-quarter-2018-financial-results\" target=\"_blank\">Press release</a>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389837-impinj-beats-0_09-beats-revenue\" target=\"_blank\">Impinj beats by $0.09, beats on revenue</a> (Sept. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389847\" data-linked=\"Impinj +28% on Q2 beats, upside guide; Audit Committee closes investigation\" data-tweet=\"$PI - Impinj +28% on Q2 beats, upside guide; Audit Committee closes investigation https://seekingalpha.com/news/3389847-impinjplus-28-on-q2-beats-upside-guide-audit-committee-closes-investigation?source=tweet\" data-url=\"https://seekingalpha.com/news/3389847-impinjplus-28-on-q2-beats-upside-guide-audit-committee-closes-investigation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389842\" data-ts=\"1536784946\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLNE\" target=\"_blank\">HLNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389842-hamilton-lane-insiders-cashing-out\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hamilton Lane insiders cashing out</a></h4><ul><li>Hamilton Lane (NASDAQ:<a href='https://seekingalpha.com/symbol/HLNE' title='Hamilton Lane Inc'>HLNE</a>) is offering 2.88M shares by the company and certain selling shareholders.</li><li>Proceeds will be used to redeem membership units in the operating partnership. HLNE will see no proceeds.</li><li>Shares&nbsp;<font color='red'>down 1.1%</font>&nbsp;after hours</li><li>Source: <a href=\"https://seekingalpha.com/pr/17268455-hamilton-lane-announces-public-offering-class-common-stock\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3389842\" data-linked=\"Hamilton Lane insiders cashing out\" data-tweet=\"$HLNE - Hamilton Lane insiders cashing out https://seekingalpha.com/news/3389842-hamilton-lane-insiders-cashing-out?source=tweet\" data-url=\"https://seekingalpha.com/news/3389842-hamilton-lane-insiders-cashing-out\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389840\" data-ts=\"1536784715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGND\" target=\"_blank\">LGND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389840-sec-charges-ligand-pharma-short-seller-short-and-distort-scheme\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SEC charges Ligand Pharma short seller with &quot;short and distort&quot; scheme</a></h4><ul><li>The SEC has <a href=\"https://www.sec.gov/news/press-release/2018-190\" target=\"_blank\">charged </a>hedge fund advisor Gregory Lemelson and Lemelson Capital Management LLC with illegally profiting from a \"short and distort\" scheme to drive down the price of Ligand Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LGND' title='Ligand Pharmaceuticals Incorporated'>LGND</a>), an effort that reportedly netted more than $1.3M in profits.</li><li>Mr. Lemelson allegedly made false statements that the company was on the verge of bankruptcy and its flagship hep C drug Promacta was going to be obsolete. He also cited a European doctor's negative view on Promacta without revealing that the physician was the largest investor in The Amvona Fund, which Mr. Lemelson shorted LGND on behalf of.</li><li>The SEC's complaints seeks the disgorgement of profits plus interest and monetary penalties.</li><li>Shares are off&nbsp;<font color='red'>1%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389840\" data-linked=\"SEC charges Ligand Pharma short seller with &quot;short and distort&quot; scheme\" data-tweet=\"$LGND - SEC charges Ligand Pharma short seller with &quot;short and distort&quot; scheme https://seekingalpha.com/news/3389840-sec-charges-ligand-pharma-short-seller-short-and-distort-scheme?source=tweet\" data-url=\"https://seekingalpha.com/news/3389840-sec-charges-ligand-pharma-short-seller-short-and-distort-scheme\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389837\" data-ts=\"1536784549\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PI\" target=\"_blank\">PI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389837-impinj-beats-0_09-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Impinj beats by $0.09, beats on revenue</a></h4><ul><li>Impinj (NASDAQ:<a href='https://seekingalpha.com/symbol/PI' title='Impinj, Inc.'>PI</a>): Q2 Non-GAAP EPS of -$0.19 <span style=\"color:green\">beats by $0.09</span>; GAAP EPS of -$0.36.</li><li>Revenue of $28.54M (-16.3% Y/Y) <font color='green'>beats by $1.21M</font>.</li><li>Shares <font color='green'>+4.1%</font>.</li><li><a href='https://seekingalpha.com/pr/17268451-impinj-reports-full-second-quarter-2018-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3389837\" data-linked=\"Impinj beats by $0.09, beats on revenue\" data-tweet=\"$PI - Impinj beats by $0.09, beats on revenue https://seekingalpha.com/news/3389837-impinj-beats-0_09-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3389837-impinj-beats-0_09-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389831\" data-ts=\"1536784190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVTL\" target=\"_blank\">PVTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389831-pivotal-softwareminus-16_2-despite-q2-beats-upside-fy-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pivotal Software -16.2% despite Q2 beats, upside FY guidance</a></h4><ul><li>        Pivotal Software (NYSE:<a href='https://seekingalpha.com/symbol/PVTL' title='Pivotal Software'>PVTL</a>)&nbsp;<font color='red'>plunges 16.2%</font>&nbsp;aftermarket despite Q2 results that beat revenue and EPS estimates. Q3 guidance has upside revenue of $163M to $165M (consensus: $162.89M) and in-line EPS of -$0.09 to -$0.08 (consensus: -$0.09).</li><li>               Upside FY19 guidance has revenue of $647M to $653M (consensus: $646.52M) and EPS of -$0.36 to -$0.34 (consensus: -$0.38).&nbsp;</li><li>               Revenue breakdown: Subscriptions, $97.5M (consensus: $92.5M); Services, $66.9M (consensus: $65.6M).&nbsp;</li><li>               Earnings call is at 5 PM with a webcast available <a href=\"https://investors.pivotal.io/home/default.aspx\" target=\"_blank\">here</a>.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17268402-pivotal-reports-second-quarter-fiscal-year-2019-financial-results\" target=\"_blank\">Press release. </a>&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389818-pivotal-software-beats-0_03-beats-revenue\" target=\"_blank\">Pivotal Software beats by $0.03, beats on revenue</a> (Sept. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389831\" data-linked=\"Pivotal Software -16.2% despite Q2 beats, upside FY guidance\" data-tweet=\"$PVTL - Pivotal Software -16.2% despite Q2 beats, upside FY guidance https://seekingalpha.com/news/3389831-pivotal-softwareminus-16_2-despite-q2-beats-upside-fy-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3389831-pivotal-softwareminus-16_2-despite-q2-beats-upside-fy-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389830\" data-ts=\"1536784174\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZLAB\" target=\"_blank\">ZLAB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389830-zai-lab-conference-call-tomorrow-on-novocure-deal-shares-up-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zai Lab conference call tomorrow on Novocure deal; shares up 1% after hours</a></h4><ul><li>Zai Lab Limited (NASDAQ:<a href='https://seekingalpha.com/symbol/ZLAB' title='Zai Lab Ltd.'>ZLAB</a>) will host a <a href=\"https://seekingalpha.com/pr/17268430-zai-lab-host-conference-call-discuss-license-collaboration-agreement-novocure-tumor-treating\" target=\"_blank\">conference call</a> tomorrow, September 13, at 8:30 am ET to discuss its license and collaboration agreement with Novocure.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389636-novocure-zai-lab-collaborates-tumor-treating-fields-greater-china\" target=\"_blank\">Novocure and Zai Lab collaborates for Tumor Treating Fields in Greater China</a> (Sept. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389830\" data-linked=\"Zai Lab conference call tomorrow on Novocure deal; shares up 1% after hours\" data-tweet=\"$ZLAB - Zai Lab conference call tomorrow on Novocure deal; shares up 1% after hours https://seekingalpha.com/news/3389830-zai-lab-conference-call-tomorrow-on-novocure-deal-shares-up-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3389830-zai-lab-conference-call-tomorrow-on-novocure-deal-shares-up-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389826\" data-ts=\"1536783820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRD\" target=\"_blank\">TLRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389826-tailored-brandsminus-6-after-sales-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tailored Brands -6% after sales miss</a></h4><ul><li>Tailored Brands (NYSE:<a href='https://seekingalpha.com/symbol/TLRD' title='Tailored Brands, Inc'>TLRD</a>) misses consensus estimates with its <a href=\"https://seekingalpha.com/pr/17268418-tailored-brands-inc-reports-fiscal-2018-second-quarter-results\" target=\"_blank\">Q2</a> revenue tally.</li><li>Comparable sales were up across all the company's brands, ranging from +3.7% for the Moore's business to +1.0% for the Men's Warehouse business.</li><li>Retail segment gross margin fell 160 bps Y/Y, primarily due to the decrease in rental services revenue and deleveraging of occupancy costs as a percent of sales.</li><li>FY comparable sales forecast: \"The company continues to expect comparable sales for Men's Wearhouse and Jos. A. Bank to be positive low-single-digits. The company is increasing its outlook for Moores comparable sales to be positive low-single-digits, up from flat-to-up slightly, and raising its outlook for K&amp;G comparable sales to be flat-to-up slightly, up from flat-to-down slightly.\"</li><li>Shares of Tailored Brands are&nbsp;<font color='red'>down 5.66%</font>&nbsp;in AH trading.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389821-tailored-brands-eps-line-misses-revenue\" target=\"_blank\">Tailored Brands EPS in-line, misses on revenue</a> (Sept. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389826\" data-linked=\"Tailored Brands -6% after sales miss\" data-tweet=\"$TLRD - Tailored Brands -6% after sales miss https://seekingalpha.com/news/3389826-tailored-brandsminus-6-after-sales-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3389826-tailored-brandsminus-6-after-sales-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389823\" data-ts=\"1536783456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XENE\" target=\"_blank\">XENE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389823-xenon-pharma-readies-stock-offering-shares-down-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xenon Pharma readies stock offering; shares down 1% after hours</a></h4><ul><li>Xenon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/XENE' title='Xenon Pharmaceuticals'>XENE</a>) is down&nbsp;<font color='red'>1%&nbsp;</font>after hours in response to its planned <a href=\"https://seekingalpha.com/pr/17268366-xenon-pharmaceuticals-announces-proposed-public-offering-common-shares\" target=\"_blank\">public offering</a> of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389823\" data-linked=\"Xenon Pharma readies stock offering; shares down 1% after hours\" data-tweet=\"$XENE - Xenon Pharma readies stock offering; shares down 1% after hours https://seekingalpha.com/news/3389823-xenon-pharma-readies-stock-offering-shares-down-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3389823-xenon-pharma-readies-stock-offering-shares-down-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389800\" data-ts=\"1536783221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PGNX\" target=\"_blank\">PGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389800-progenics-pharma-shares-halted-pending-news\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progenics Pharma shares halted pending news</a></h4><ul><li>Nasdaq has suspended trading in Progenics Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PGNX' title='Progenics Pharmaceuticals Inc.'>PGNX</a>) pending the release of news.</li><li><strong>Update</strong>: A Phase 3 clinical trial evaluating its SPECT/CT imaging agent for visualizing prostate cancer <a href=\"https://seekingalpha.com/pr/17268369-progenics-pharmaceuticals-reports-top-line-phase-3-data-prostate-cancer-imaging-agent-1404\" target=\"_blank\">failed the sensitivity endpoint</a>. Specifically, sensitivity was 47 - 51%, below the protocol's required lower limit of 60%. The specificity objective was met.</li><li>CEO Mark Baker says, &ldquo;These top line Phase 3 results of 1404 are inconsistent with the prior Phase 2 data, which showed significantly higher sensitivity rates. We are currently conducting a thorough analysis of the full data set to understand the factors that may have contributed to this outcome and determine the appropriate development path for this novel agent in patients with low-grade prostate cancer. We plan to complete this review in the next quarter.&rdquo;</li><li>Shares will resume trading at 4:30 pm ET.</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>18%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389800\" data-linked=\"Progenics Pharma shares halted pending news\" data-tweet=\"$PGNX - Progenics Pharma shares halted pending news https://seekingalpha.com/news/3389800-progenics-pharma-shares-halted-pending-news?source=tweet\" data-url=\"https://seekingalpha.com/news/3389800-progenics-pharma-shares-halted-pending-news\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389795\" data-ts=\"1536780899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VERU\" target=\"_blank\">VERU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389795-veru-nearing-launch-of-study-on-veruminus-111-in-treatment-resistant-prostate-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veru nearing launch of study on VERU-111 in treatment-resistant prostate cancer; investors unmoved, shares down 14%</a></h4><ul><li>Thinly traded nano cap Veru (<a href='https://seekingalpha.com/symbol/VERU' title='Veru Inc.'>VERU</a> <font color='red'>-14.1%</font>) is down on more than a 5x surge in volume despite its <a href=\"https://seekingalpha.com/pr/17267328-veru-successful-pre-ind-meeting-fda-veruminus-111-next-generation-novel-oral-anti-tubulin\" target=\"_blank\">announcement</a> that the FDA has agreed with its plans for a Phase 1/2 clinical trial evaluating oral chemo agent <a href=\"https://verupharma.com/pipeline/veru-111/\" target=\"_blank\">VERU-111</a> in patients with metastatic castration-resistant prostate cancer who have become resistant to or have failed to respond adequately to Johnson &amp; Johnson's ZYTIGA (abiraterone acetate) or Pfizer's XTANDI (enzalutamide).</li><li>The company plans to file an IND and commence the open-label study by year-end. Preliminary data should be available in Q1 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389795\" data-linked=\"Veru nearing launch of study on VERU-111 in treatment-resistant prostate cancer; investors unmoved, shares down 14%\" data-tweet=\"$VERU - Veru nearing launch of study on VERU-111 in treatment-resistant prostate cancer; investors unmoved, shares down 14% https://seekingalpha.com/news/3389795-veru-nearing-launch-of-study-on-veruminus-111-in-treatment-resistant-prostate-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3389795-veru-nearing-launch-of-study-on-veruminus-111-in-treatment-resistant-prostate-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389783\" data-ts=\"1536777973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHC\" target=\"_blank\">VHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389783-technology-top-5-gainers-losers-of-2_45-pm-09-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.45 PM (09/12/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/BILI' title='Bilibili'>BILI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/BKTI' title='RELM Wireless Corporation'>BKTI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/ADTN' title='ADTRAN, Inc.'>ADTN</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>USAT</a> <font color='green'>+12%</font>.</li>      <li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/RDVT' title='Red Violet, Inc.'>RDVT</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/LTRX' title='Lantronix, Inc.'>LTRX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MTSI' title='MACOM Technology Solutions Holdings, Inc.'>MTSI</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SGMA' title='SigmaTron International, Inc.'>SGMA</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/STRM' title='Streamline Health Solutions, Inc.'>STRM</a>&nbsp;&nbsp;<font color='red'>-10%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3389783\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.45 PM (09/12/2018)\" data-tweet=\"$VHC $VHC $BILI - Technology - Top 5 Gainers / Losers as of 2.45 PM (09/12/2018) https://seekingalpha.com/news/3389783-technology-top-5-gainers-losers-of-2_45-pm-09-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389783-technology-top-5-gainers-losers-of-2_45-pm-09-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389782\" data-ts=\"1536777447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389782-sprint-unveils-latest-iteration-of-magic-box\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint unveils latest iteration of Magic Box</a></h4><ul>   <li>Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color='green'>+3.5%</font>) is making its <a href=\"https://seekingalpha.com/pr/17268236-sprint-announces-faster-powerful-smaller-sprint-magic-box\" target=\"_blank\">small cell a bit smaller</a>.</li>    <li>The company's rolling out its business-focused Magic Box Generation 3, which is set to be faster and more powerful along with the reduced size.</li>    <li>It starts up quicker, Sprint says, and offers speeds up to 25% faster than the last model.</li>    <li>In tech specs, it's LTE Advanced-capable and uses 4x4 MIMO, higher order modulation (256QAM) and three-carrier aggregation in Sprint's licensed spectrum. It also has Wi-Fi backhaul so it can work with a Wi-Fi connection if wireless coverage isn't available.</li>    <li>The new box will be available later this year. More than 260,000 Magic Boxes have been distributed in more than 200 cities since a May 2017 launch.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389782\" data-linked=\"Sprint unveils latest iteration of Magic Box\" data-tweet=\"$S - Sprint unveils latest iteration of Magic Box https://seekingalpha.com/news/3389782-sprint-unveils-latest-iteration-of-magic-box?source=tweet\" data-url=\"https://seekingalpha.com/news/3389782-sprint-unveils-latest-iteration-of-magic-box\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>72&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389781\" data-ts=\"1536776912\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SDRL\" target=\"_blank\">SDRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389781-seadrill-ready-to-make-deals-amid-rig-market-consolidation-ceo-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seadrill ready to make deals amid rig market consolidation, CEO says</a></h4><ul>     <li>Seadrill (<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='green'>+3.2%</font>) is higher after CEO Anton Dibowitz told Reuters in an interview that the company is <a href=\"https://www.reuters.com/article/seadrill-ma/seadrill-ceo-eyes-rig-market-consolidation-as-oil-prices-rise-idUSL5N1VY0M9\" target=\"_blank\">poised to make acquisitions</a> if opportunities arise, as higher energy prices may spark consolidation in the industry.</li>     <li>Competitor Transocean announced earlier this month that it would buy deepwater driller Ocean Rig for $2.7B, and &ldquo;based on the number of conversations, I believe there will be more deals,\" Dibowitz said. \"There is still a significant amount of fleet renewal that needs to happen among our competitors.\"</li><li>Dibowitz also says SDRL has \"a history of doing transactions, and we are certainly not going to sit on our hands.\"</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3389781\" data-linked=\"Seadrill ready to make deals amid rig market consolidation, CEO says\" data-tweet=\"$SDRL - Seadrill ready to make deals amid rig market consolidation, CEO says https://seekingalpha.com/news/3389781-seadrill-ready-to-make-deals-amid-rig-market-consolidation-ceo-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3389781-seadrill-ready-to-make-deals-amid-rig-market-consolidation-ceo-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389779\" data-ts=\"1536776584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389779-heavyweight-tesla-investor-chimes-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heavyweight Tesla investor chimes in</a></h4><ul><li>One of Tesla's (<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a> <font color='green'>+3.3%</font>) largest institutional investors has <a href=\"https://www.reuters.com/article/us-tesla-musk-investor/tesla-investor-spoke-with-sec-about-funding-secured-tweet-idUSKCN1LS2RD\" target=\"_blank\">spoken</a> to Reuters about some of the latest developments at the EV automaker.</li><li>Baillie Gifford confirms that it talked to the SEC in August about Elon Musk's plan to take the company private and concedes that Musk needs some assistance in the C-Suite.</li><li>\"He needs help, and I mean that psychologically as much as practically,\" says asset manager Baillie Gifford&rsquo;s James Anderson (fund manager of Scottish Mortgage Investment Trust).</li><li>Anderson says Musk is \"getting there\" on the concept of bringing in managerial help, which could include adding a chief operating officer position at the company.</li><li>On the subject of Musk's use of Twitter for communication about Tesla, Anderson says he told the exec that it wasn't a great thing.</li><li>Baillie held 13.17M shares of Tesla at the end of Q1, giving it a voice in the room.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389779\" data-linked=\"Heavyweight Tesla investor chimes in\" data-tweet=\"$TSLA - Heavyweight Tesla investor chimes in https://seekingalpha.com/news/3389779-heavyweight-tesla-investor-chimes-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3389779-heavyweight-tesla-investor-chimes-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>233&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389776\" data-ts=\"1536776266\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NGD\" target=\"_blank\">NGD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389776-new-gold-reportedly-exploring-sale-sharesplus-25\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Gold reportedly exploring sale, shares +25%</a></h4><ul>     <li>New Gold (<a href='https://seekingalpha.com/symbol/NGD' title='New Gold Inc'>NGD</a> <font color='green'>+25.8%</font>) surges following a Reuters report that it is <a href=\"https://www.reuters.com/article/us-new-gold-m-a/canadian-miner-new-gold-explores-sale-sources-say-idUSKCN1LS2MR\" target=\"_blank\">exploring a sale</a> and is working with investment bank BMO Capital Markets to help find a buyer and evaluate other options.</li>     <li>NGD could divest specific mines if an outright sale does not materialize, according to the report, which notes the New Afton mine in British Columbia and Mesquite mine in California may be appealing on a standalone basis.</li>     <li>NGD has struggled to hit production targets at its flagship Rainy River mine in Ontario, which could make it harder to pull off a sale since any buyer must be comfortable with the mine&rsquo;s operational problems as well as company debt.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389776\" data-linked=\"New Gold reportedly exploring sale, shares +25%\" data-tweet=\"$NGD - New Gold reportedly exploring sale, shares +25% https://seekingalpha.com/news/3389776-new-gold-reportedly-exploring-sale-sharesplus-25?source=tweet\" data-url=\"https://seekingalpha.com/news/3389776-new-gold-reportedly-exploring-sale-sharesplus-25\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389772\" data-ts=\"1536775771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MMM\" target=\"_blank\">MMM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389772-3m-warns-on-materials-costs-shares-down-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">3M warns on materials costs; shares down more than 2%</a></h4><ul><li>Speaking at a conference, 3M (<a href='https://seekingalpha.com/symbol/MMM' title='3M Company'>MMM</a> <font color='red'>-2.5%</font>) CFO Nick Gangestad says rising raw materials prices could knock $0.10 per share from earnings this year. That's the top end of previous guidance of $0.05-$0.10.</li><li>Honeywell (<a href='https://seekingalpha.com/symbol/HON' title='Honeywell International, Inc.'>HON</a> <font color='green'>+0.5%</font>) and Illinois Tool Works (<a href='https://seekingalpha.com/symbol/ITW' title='Illinois Tool Works Inc.'>ITW</a> <font color='green'>+0.2%</font>) remain modestly green on the session, but have dipped on the 3M remarks.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389772\" data-linked=\"3M warns on materials costs; shares down more than 2%\" data-tweet=\"$MMM $MMM $HON - 3M warns on materials costs; shares down more than 2% https://seekingalpha.com/news/3389772-3m-warns-on-materials-costs-shares-down-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3389772-3m-warns-on-materials-costs-shares-down-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389771\" data-ts=\"1536775578\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389771-apple-suppliers-to-watch-during-fall-event\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple suppliers to watch during the fall event</a></h4><ul><li>Suppliers that could move on news from Apple's iPhone launch event:&nbsp;  Broadcom (<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a> <font color='red'>-1.7%</font>), Cirrus Logic (<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a> <font color='green'>+0.4%</font>), Finisar (<a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a> <font color='red'>-0.4%</font>), II-VI (<a href='https://seekingalpha.com/symbol/IIVI' title='II-VI Incorporated'>IIVI</a> <font color='green'>+0.6%</font>), Lumentum (<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a> <font color='red'>-1.6%</font>), Qorvo (<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a> <font color='red'>-1.4%</font>), Skyworks Solutions (<a href='https://seekingalpha.com/symbol/SWKS' title='Skyworks Solutions, Inc.'>SWKS</a> <font color='red'>-2.2%</font>), STMicroelectronics (<a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a> <font color='red'>-3.1%</font>), Universal Display (<a href='https://seekingalpha.com/symbol/OLED' title='Universal Display Corporation'>OLED</a> <font color='red'>-0.9%</font>), TSMC (<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Ltd.'>TSM</a> <font color='red'>-1.2%</font>), Dolby (<a href='https://seekingalpha.com/symbol/DLB' title='Dolby Laboratories, Inc.'>DLB</a> <font color='green'>+0.3%</font>).&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389751-apples-fall-iphone-event-live-updates\" target=\"_blank\">Apple's fall iPhone event (live updates)</a> (Sept. 12)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389764-fitbit-minus-4_8-percent-apple-rolls-newest-watch\" target=\"_blank\">Fitbit -4.8% as Apple rolls out newest Watch</a> (Sept. 12)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389765-irhythm-5-percent-fda-ok-apples-ecg-heart-health-apps\" target=\"_blank\">IRhythm down 5% on FDA OK for Apple's ECG and heart health apps</a> (Sept. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389771\" data-linked=\"Apple suppliers to watch during the fall event\" data-tweet=\"$AVGO $AVGO $CRUS - Apple suppliers to watch during the fall event https://seekingalpha.com/news/3389771-apple-suppliers-to-watch-during-fall-event?source=tweet\" data-url=\"https://seekingalpha.com/news/3389771-apple-suppliers-to-watch-during-fall-event\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389770\" data-ts=\"1536775419\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOGO\" target=\"_blank\">GOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389770-gogo-up-nearly-10-bearish-analyst-boosts-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gogo up nearly 10% as bearish analyst boosts estimates</a></h4><ul><li>Morgan Stanley's Simon Flannery remains a bear on Gogo (<a href='https://seekingalpha.com/symbol/GOGO' title='Gogo'>GOGO</a> <font color='green'>+9.2%</font>), but he's seeing \"signs of stabilization,\" and boosting his EBITDA estimate for this year to $45M from $40M, and next year to $84M from $77M.</li><li>Company is guidance for 2018 is $35M-$45M.</li><li>Concerns over the business model, leverage, and cash burn remain, says Flannery.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3389770\" data-linked=\"Gogo up nearly 10% as bearish analyst boosts estimates\" data-tweet=\"$GOGO - Gogo up nearly 10% as bearish analyst boosts estimates https://seekingalpha.com/news/3389770-gogo-up-nearly-10-bearish-analyst-boosts-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3389770-gogo-up-nearly-10-bearish-analyst-boosts-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>74&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389769\" data-ts=\"1536775256\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KHC\" target=\"_blank\">KHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389769-rbc-sees-upside-in-packaged-food-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC sees upside in packaged food sector</a></h4><ul><li>Kraft Heinz (NASDAQ:<a href='https://seekingalpha.com/symbol/KHC' title='The Kraft Heinz Company'>KHC</a>)&nbsp;trades&nbsp;<font color='green'>2.2% higher</font>&nbsp;after RBC analyst David Palmer raises the company up to number two on its ranking of packaged food stocks.</li><li>RBC warms up to Kraft following the 24% YTD share price decline pushed valuation to a more attractive level.</li><li>Palmer and team keep Conagra (<a href='https://seekingalpha.com/symbol/CAG' title='ConAgra Brands, Inc.'>CAG</a> <font color='green'>+1.1%</font>) as the top pick in the group due to its category exposure, synergy potential after the Pinnacle Foods (NYSE:<a href='https://seekingalpha.com/symbol/PF' title='Pinnacle Foods'>PF</a>)&nbsp;deal and what it called \"reasonable\" valuation.</li><li>Also within the packaged food sector, price targets are bumped up on Kellogg (<a href='https://seekingalpha.com/symbol/K' title='Kellogg Company'>K</a> <font color='green'>+1.2%</font>) and Hershey (<a href='https://seekingalpha.com/symbol/HSY' title='The Hershey Company'>HSY</a> <font color='green'>+1.6%</font>).&nbsp; General Mills (<a href='https://seekingalpha.com/symbol/GIS' title='General Mills, Inc.'>GIS</a> <font color='green'>+1.6%</font>), TreeHouse Foods (<a href='https://seekingalpha.com/symbol/THS' title='TreeHouse Foods, Inc.'>THS</a> <font color='green'>+1.4%</font>) and Flower Foods (<a href='https://seekingalpha.com/symbol/FLO' title='Flowers Foods, Inc.'>FLO</a> <font color='green'>+1.1%</font>) are all perky on the day amid the RBC&nbsp;attention on food sector valuations and revenue improvement potential</li><li>Sources: Bloomberg, CNBC</li><li>Related ETF: <a href='https://seekingalpha.com/symbol/PBJ' title='Invesco Dynamic Food & Beverage Portfolio ETF'>PBJ</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3389769\" data-linked=\"RBC sees upside in packaged food sector\" data-tweet=\"$KHC $KHC $CAG - RBC sees upside in packaged food sector https://seekingalpha.com/news/3389769-rbc-sees-upside-in-packaged-food-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3389769-rbc-sees-upside-in-packaged-food-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389767\" data-ts=\"1536775215\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EC\" target=\"_blank\">EC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389767-energy-materials-top-5-gainers-losers-of-2-00-pm-09-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (09/12/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EC' title='Ecopetrol S.A.'>EC</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Co.'>HL</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/LPI' title='Laredo Petroleum Holdings, Inc.'>LPI</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/AGI' title='Alamos Gold Inc'>AGI</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/SILV' title='SilverCrest Metals, Inc.'>SILV</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/JONE' title='Jones Energy, Inc.'>OTC:JONE</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/TGA' title='Transglobe Energy Corp'>TGA</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389767\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (09/12/2018)\" data-tweet=\"$EC $EC $HL - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (09/12/2018) https://seekingalpha.com/news/3389767-energy-materials-top-5-gainers-losers-of-2-00-pm-09-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389767-energy-materials-top-5-gainers-losers-of-2-00-pm-09-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389765\" data-ts=\"1536774613\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRTC\" target=\"_blank\">IRTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389765-irhythm-down-5-on-fda-ok-for-apples-ecg-and-heart-health-apps\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IRhythm down 5% on FDA OK for Apple&#39;s ECG and heart health apps</a></h4><ul><li>IRhythm Technologies (<a href='https://seekingalpha.com/symbol/IRTC' title='iRhythm Technologies'>IRTC</a> <font color='red'>-5.1%</font>) slips on below-average volume in apparent reaction to the <a href=\"https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm620246.htm\" target=\"_blank\">news </a>that the FDA has cleared Apple's ECG and cardiac health apps for use in its Series 4 watch.</li><li>IRTC provides cardiac monitoring services via <a href=\"https://www.irhythmtech.com/products-services/zio-xt\" target=\"_blank\">Zio XT</a>, a combination of a wearable biosensor with cloud-based analytics and machine-learning capabilities.</li><li>Another company operating in the mobile cardiac monitoring space is privately held <a href=\"https://www.getqardio.com/en\" target=\"_blank\">Qardio</a>, based in San Francisco.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389765\" data-linked=\"IRhythm down 5% on FDA OK for Apple&#39;s ECG and heart health apps\" data-tweet=\"$IRTC - IRhythm down 5% on FDA OK for Apple&#39;s ECG and heart health apps https://seekingalpha.com/news/3389765-irhythm-down-5-on-fda-ok-for-apples-ecg-and-heart-health-apps?source=tweet\" data-url=\"https://seekingalpha.com/news/3389765-irhythm-down-5-on-fda-ok-for-apples-ecg-and-heart-health-apps\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389764\" data-ts=\"1536773723\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIT\" target=\"_blank\">FIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389764-fitbitminus-4_8-apple-rolls-out-newest-watch\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fitbit -4.8% as Apple rolls out newest Watch</a></h4><ul>   <li>With Tim Cook extolling the new features of the Apple Watch Series 4, rival wearable maker Fitbit (NYSE:<a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a>) has <font color='red'>slid 4.8%</font>, a low for the past month.</li>    <li>Shares of Fitbit are <font color='green'>up 4%</font> YTD but have <font color='red'>declined 21.7%</font> over the past quarter.</li>    <li>See live updates of Apple's <a href=\"https://seekingalpha.com/news/3389751-apples-fall-iphone-event-live-updates\" target=\"_blank\">ongoing announcement event here</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389764\" data-linked=\"Fitbit -4.8% as Apple rolls out newest Watch\" data-tweet=\"$FIT - Fitbit -4.8% as Apple rolls out newest Watch https://seekingalpha.com/news/3389764-fitbitminus-4_8-apple-rolls-out-newest-watch?source=tweet\" data-url=\"https://seekingalpha.com/news/3389764-fitbitminus-4_8-apple-rolls-out-newest-watch\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389763\" data-ts=\"1536773593\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIT\" target=\"_blank\">FIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389763-fitbitminus-4-apple-unveils-new-watch-series\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fitbit -4% as Apple unveils new Watch series</a></h4><ul><li>Fitbit (NYSE:<a href='https://seekingalpha.com/symbol/FIT' title='Fitbit, Inc.'>FIT</a>) is&nbsp;<font color='red'>down 3.6% </font>in a sudden break lower after Apple announces details on its new Watch Series 4.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389751-apples-fall-iphone-event-live-updates\" target=\"_blank\">Apple's fall iPhone event (live updates)</a> (Sept. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389763\" data-linked=\"Fitbit -4% as Apple unveils new Watch series\" data-tweet=\"$FIT - Fitbit -4% as Apple unveils new Watch series https://seekingalpha.com/news/3389763-fitbitminus-4-apple-unveils-new-watch-series?source=tweet\" data-url=\"https://seekingalpha.com/news/3389763-fitbitminus-4-apple-unveils-new-watch-series\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389762\" data-ts=\"1536773571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CADE\" target=\"_blank\">CADE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389762-cadence-bancorporation-announces-pricing-of-common-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cadence Bancorporation announces pricing of common stock</a></h4><ul>     <li>Cadence Bancorp (<a href='https://seekingalpha.com/symbol/CADE' title='Cadence Bancorporation'>CADE</a> <font color='red'>-2.3%</font>) prices 12,099,757 common stock offering at $27.55/share.</li>     <li>The offering is expected to close on or about Sept. 14, 2018, subject to customary closing conditions.</li>     <li>CADE is not selling any shares of Class A common stock and will not receive any proceeds from the proposed offering.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3389508-cadence-bancorp-minus-1_6-percent-12_1m-share-sale-stockholders\" target=\"_blank\">Cadence Bancorp -1.6% on 12.1M-share sale from stockholders</a> (Sept. 11)</li>     <li><a href=\"http://www.cadencebancorporation.com/file/Index?KeyFile=394974203\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3389762\" data-linked=\"Cadence Bancorporation announces pricing of common stock\" data-tweet=\"$CADE - Cadence Bancorporation announces pricing of common stock https://seekingalpha.com/news/3389762-cadence-bancorporation-announces-pricing-of-common-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/3389762-cadence-bancorporation-announces-pricing-of-common-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389754\" data-ts=\"1536771646\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIFS\" target=\"_blank\">CIFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389754-financials-top-gainers-losers-of-1-00-pm-09-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (09/12/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/GSHD' title='Goosehead Insurance'>GSHD</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/EMITF' title='Elbit Imaging Ltd.'>EMITF</a> <font color='green'>+6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389754\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (09/12/2018)\" data-tweet=\"$CIFS $CIFS $MHLD - Financials - Top Gainers / Losers as of 1:00 PM (09/12/2018) https://seekingalpha.com/news/3389754-financials-top-gainers-losers-of-1-00-pm-09-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389754-financials-top-gainers-losers-of-1-00-pm-09-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389753\" data-ts=\"1536771536\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIN\" target=\"_blank\">WIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389753-windstream-expands-fixed-wireless-business-offering-to-50-markets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Windstream expands fixed wireless business offering to 50 markets</a></h4><ul>   <li>Windstream Enterprise (<a href=\"http://seekingalpha.com/symbol/WIN\" target=\"_blank\">WIN</a> <font color='green'>+5.3%</font>) now says fixed wireless service is available in <a href=\"https://seekingalpha.com/pr/17267801-windstream-enterprise-expands-fixed-wireless-service-50-markets\" target=\"_blank\">more than 50 markets</a>.</li>    <li>After the launch of a fixed wireless core site in Houston, Windstream Enterprise's service area covers more than 350,000 prequalified businesses, it says.</li>    <li>The offering runs in parallel to the company's core fiber footprint, and promises connection speeds between 1.5 Mbps to 5 Gbps with service delivery time under 45 days.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389753\" data-linked=\"Windstream expands fixed wireless business offering to 50 markets\" data-tweet=\"$WIN $WINMQ - Windstream expands fixed wireless business offering to 50 markets https://seekingalpha.com/news/3389753-windstream-expands-fixed-wireless-business-offering-to-50-markets?source=tweet\" data-url=\"https://seekingalpha.com/news/3389753-windstream-expands-fixed-wireless-business-offering-to-50-markets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389752\" data-ts=\"1536770913\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BA\" target=\"_blank\">BA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389752-boeingplus-3-on-possible-china-talks-ceo-says-737-recovery-taking-hold\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boeing +3% on possible China talks; CEO says 737 recovery &#39;taking hold&#39;</a></h4><ul>     <li>Boeing (<a href='https://seekingalpha.com/symbol/BA' title='The Boeing Company'>BA</a> <font color='green'>+2.7%</font>) leads all gainers on the Dow after saying it expects to <a href=\"https://www.reuters.com/article/us-boeing-production/boeing-737-recovery-plan-taking-hold-after-factory-snarl-ceo-idUSKCN1LS2I7\" target=\"_blank\">deliver roughly as many 737 jetliners</a> in September as it delivered in August, and <em>WSJ</em> reports the U.S. has reached out to China <a href=\"https://seekingalpha.com/news/3389730-stocks-jump-u-s-reportedly-proposes-new-round-trade-talks-china\" target=\"_blank\">seeking a new round of trade talks</a>.</li>     <li>&ldquo;Our recovery actions are taking hold,&rdquo; CEO Dennis Muilenburg said at a conference in California. &ldquo;You&rsquo;ll probably see September deliveries will be roughly where August was, maybe a little bit better... As we get into the fourth quarter, you will see deliveries getting above the 52 per month production rate.\"</li>     <li>Boeing&rsquo;s <a href=\"https://seekingalpha.com/news/3389399-boeing-737-deliveries-bounce-48-august-29-july\" target=\"_blank\">August delivery</a> of 48 narrowbody aircraft was an improvement from the 29 delivered in July as the company tries to rebound from a manufacturing bottleneck due to supplier delays.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389752\" data-linked=\"Boeing +3% on possible China talks; CEO says 737 recovery &#39;taking hold&#39;\" data-tweet=\"$BA - Boeing +3% on possible China talks; CEO says 737 recovery &#39;taking hold&#39; https://seekingalpha.com/news/3389752-boeingplus-3-on-possible-china-talks-ceo-says-737-recovery-taking-hold?source=tweet\" data-url=\"https://seekingalpha.com/news/3389752-boeingplus-3-on-possible-china-talks-ceo-says-737-recovery-taking-hold\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389751\" data-ts=\"1536770727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389751-apples-fall-iphone-event-live-updates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple&#39;s fall iPhone event (live updates)</a></h4><ul><li>Quick recap: Apple announced the expected three iPhone models with the also expected LCD model release delay. The Apple Watch gets new health features including the ability to sense falls. And still no word on the AirPower charging mat.</li><li><b>iPhone prices and dates: </b>XR comes in three storage sizes starting at $749 with a delayed release (rumored due to production issues) schedule with preorders October 19 and shipment October 26.&nbsp; The XS comes in 64GB, 256GB, and 512GB starting at $999 and the XS Max with the same storage starting at $1,099 with preorders starting Friday and shipping September 21.</li><li>               Older iPhone prices: iPhone 7 starts at $499, iPhone 8 at $599.&nbsp;&nbsp;</li><li><b>iPhone XR:</b> 6.1-inch edge-to-edge LCD screen with a new &ldquo;Liquid Retina&rdquo; display with 326 ppi and 1792x828, Face ID, and no Home button. Made of aerospace-grade aluminum with a more durable glass. Comes with the same TrueDepth camera features as this year&rsquo;s premium models and there&rsquo;s an updated single 12mp wide-angle camera on the back, which can do portrait mode. Battery life is 90 minutes longer than the iPhone 8 Plus.</li><li><strong>iPhone XS and Max:</strong> iPhone XS (&ldquo;ten ess&rdquo; not &ldquo;excess&rdquo;) is 5.8-inch Super Retina with OLED display, 2436x1125, 2.7M pixels, 458 ppi. Made of &ldquo;surgical-grade stainless steel&rdquo; with 60% greater dynamic colors than iPhone X. Colors: Gold, silver, space gray.</li><li>The 6.5-inch version is called the iPhone XS Max with 458 ppi, 2688x1242, 3M pixels. <br>*FaceID gets faster algorithms and Secure Enclave.</li><li>A12 bionic chip is the industry&rsquo;s first 7nm chip and has 6.9B transistors. Specs: 4-core GPU, 6-core CPU, neural engine, GPU 50% faster than A11. Neural engine can handle 600B operations/second and the A12 can do 5T operations per second.</li><li><strong>XS/Max camera updates:&nbsp;</strong>12mp wide camera and 12mp telephoto camera, improved True Tone flash. Facial &ldquo;landmarking&rdquo; for better red eye reduction and portrait mode plus a new Smart HDR feature for better photos in difficult settings. Portrait modes also get improvements including bokeh quality.</li><li>Battery life for the XS lasts 30 minutes longer than the X and the Max up to 90 minutes longer. New tech DSDS (dual SIM dual standby) runs on software-backed eSIM tech and allows users to keep two phone numbers, use two different plans, and travel with a local plan.</li><li><strong>Apple Watch: </strong>Cook says the Watch is the top-selling watch in the world, not just the smartwatch. Jeff Williams introduces the Series 4, which starts with a &ldquo;stunning new display&rdquo; with an over 30% larger screen. UI was redesigned with the larger screen in mind.</li><li>There&rsquo;s a new Watch face with richer complications. You can add contacts to the face for quick contacts. Modular face updates with info from heart sensor, stocks, and activities. The Breathe app becomes a face for breathing reminders.</li><li>The speaker is redesigned to be louder and the microphone moves to the opposite side for clearer calls. The back is black ceramic and sapphire crystal for improved cellular reception.</li><li>S4 chip inside has a new dual-core 64-bit processor and new GPU for 2x faster performance.</li><li>Fitness and health: The accelerator and gyroscope power all-day activity racking and can identify swim strokes. The Series 4 can also detect a fall and delivers an alert that can initiate an emergency call automatically if you don&rsquo;t move for over a minute.</li><li>Heart features: New heart-monitoring features include notification if the heart rate is too low, a warning of heart rhythm irregularities that seem tied to atrial fibrillation, and electrodes on the back of the Watch and the digital crown allow you to take an electrocardiogram.</li><li>Battery life still at 18 hours with six hours of outdoor workout time.</li><li>Pricing from $399 for GPS to $499 for cellular with orders opening Friday and shipping on September 21. Series 3 price drops to $279 starting today.</li><li>Apple&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) fall event will kick off at 1 PM Eastern with a live stream available on <a href=\"https://www.apple.com/apple-events/september-2018/\" target=\"_blank\">Apple&rsquo;s site</a> and Twitter. Apple TV owners can watch through the Apple Events app.</li><li>Check back after the event starts for live updates.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389456-expect-apples-iphone-launch-event\" target=\"_blank\">What to expect during Apple's iPhone launch event</a> (Sept. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389751\" data-linked=\"Apple&#39;s fall iPhone event (live updates)\" data-tweet=\"$AAPL - Apple&#39;s fall iPhone event (live updates) https://seekingalpha.com/news/3389751-apples-fall-iphone-event-live-updates?source=tweet\" data-url=\"https://seekingalpha.com/news/3389751-apples-fall-iphone-event-live-updates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>135&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389749\" data-ts=\"1536770608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NMRD\" target=\"_blank\">NMRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389749-midday-gainers-losers-09-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (09/12/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/NMRD' title='Nemaura Medical, Inc.'>NMRD</a> <font color='green'>+47%</font>. <a href='https://seekingalpha.com/symbol/XBIT' title='Xbiotech'>XBIT</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/ARCI' title='Appliance Recycling Centers of America, Inc.'>ARCI</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/SLDB' title='Solid Biosciences, Inc.'>SLDB</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/VVUS' title='Vivus, Inc.'>VVUS</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CDXC' title='ChromaDex Inc.'>CDXC</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a> <font color='green'>+13%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/VTL' title='Vital Therapies, Inc.'>VTL</a> <font color='red'>-92%</font>. <a href='https://seekingalpha.com/symbol/DHXM' title='DHX Media Ltd Variable Voting'>DHXM</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/NSSC' title='NAPCO Security Technologies, Inc.'>NSSC</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/LTRX' title='Lantronix, Inc.'>LTRX</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/AGMH' title='AGM Group Holdings Inc.'>AGMH</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/STRM' title='Streamline Health Solutions, Inc.'>STRM</a> <font color='red'>-10%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3389749\" data-linked=\"Midday Gainers / Losers (09/12/2018)\" data-tweet=\"$NMRD $NMRD $XBIT - Midday Gainers / Losers (09/12/2018) https://seekingalpha.com/news/3389749-midday-gainers-losers-09-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389749-midday-gainers-losers-09-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389748\" data-ts=\"1536770453\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELF\" target=\"_blank\">ELF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389748-analysts-buzz-over-e-l-f-beauty-takeover-scenario\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts buzz over e.l.f. Beauty takeover scenario</a></h4><ul><li>Jefferies estimates that e.l.f. Beauty (<a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a> <font color='green'>+0.5%</font>) may be worth $25 per share in a takeover scenario, per Bloomberg.</li><li>SunTrust is more conservative with an estimate of $17 as an ELF buyout price.</li><li>The M&amp;A buzz was stirred up earlier today when stakeholder Marathon Partners disclosed that it's pushing e.l.f. Beauty to pursue a sale.</li><li>Shares of e.l.f. Beauty are swapping hands at $13.47 at last check.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389616-marathon-pressure-e-l-f-beauty-sale\" target=\"_blank\">Marathon to pressure e.l.f. Beauty for sale</a> (Sept. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389748\" data-linked=\"Analysts buzz over e.l.f. Beauty takeover scenario\" data-tweet=\"$ELF - Analysts buzz over e.l.f. Beauty takeover scenario https://seekingalpha.com/news/3389748-analysts-buzz-over-e-l-f-beauty-takeover-scenario?source=tweet\" data-url=\"https://seekingalpha.com/news/3389748-analysts-buzz-over-e-l-f-beauty-takeover-scenario\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389743\" data-ts=\"1536768717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GS\" target=\"_blank\">GS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389743-goldman-sachs-losing-streak-hits-11-days\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs losing streak hits 11 days</a></h4><ul><li>While that <a href=\"https://www.bloomberg.com/news/articles/2018-09-12/goldman-sachs-shares-are-on-their-longest-losing-streak-ever?srnd=premium\" target=\"_blank\">would be the longest</a> losing streak since Goldman (<a href='https://seekingalpha.com/symbol/GS' title='Goldman Sachs Group Inc.'>GS</a> <font color='red'>-1.2%</font>) came public in 1999, the total decline (<font color='red'>now about 7%</font>) is rather modest, and just puts the stock back to its mid-August level.</li><li>For the year, Goldman is&nbsp;<font color='red'>down about 11%</font>, roughly 150 basis points worse than Morgan Stanley. JPMorgan, by contrast, is up 5%, and the XLF is about flat.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389743\" data-linked=\"Goldman Sachs losing streak hits 11 days\" data-tweet=\"$GS - Goldman Sachs losing streak hits 11 days https://seekingalpha.com/news/3389743-goldman-sachs-losing-streak-hits-11-days?source=tweet\" data-url=\"https://seekingalpha.com/news/3389743-goldman-sachs-losing-streak-hits-11-days\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389740\" data-ts=\"1536768394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389740-semi-stocks-slide-on-goldman-downgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semi stocks slide on Goldman downgrades</a></h4><ul><li>Semiconductors slide after Goldman Sachs downgraded Micron (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='red'>-5.3%</font>) on concerns of a memory downturn. The firm also downgrades the semi equipment industry from Attractive to Neutral.</li><li>Other Goldman cuts: Western Digital&rsquo;s (<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a> <font color='green'>+4.6%</font>) price target falls from $80 to $63, Seagate Technology (<a href='https://seekingalpha.com/symbol/STX' title='Seagate Technology'>STX</a> <font color='green'>+0.9%</font>) from $44 to $39, and Lam Research (<a href='https://seekingalpha.com/symbol/LRCX' title='Lam Research Corporation'>LRCX</a> <font color='red'>-2.7%</font>) from Buy to Neutral.</li><li>Other semi movers: KLA-Tencor (<a href='https://seekingalpha.com/symbol/KLAC' title='KLA-Tencor Corporation'>KLAC</a> <font color='red'>-2.7%</font>), ASML (<a href='https://seekingalpha.com/symbol/ASML' title='ASML Holding N.V.'>ASML</a> <font color='red'>-4.3%</font>),&nbsp;Applied Materials (<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a> <font color='red'>-2.3%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389641-micron-minus-4_6-percent-goldman-steps-sidelines-memory-concerns\" target=\"_blank\">Micron -4.6% as Goldman steps to sidelines on memory concerns</a> (Sept. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389740\" data-linked=\"Semi stocks slide on Goldman downgrades\" data-tweet=\"$MU $MU $WDC - Semi stocks slide on Goldman downgrades https://seekingalpha.com/news/3389740-semi-stocks-slide-on-goldman-downgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3389740-semi-stocks-slide-on-goldman-downgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>222&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389739\" data-ts=\"1536768107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KBSF\" target=\"_blank\">KBSF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389739-consumer-top-5-gainers-losers-of-12-00-pm-09-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers as of 12:00 PM (09/12/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/REED' title='Reed&#39;s, Inc.'>REED</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/MO' title='Altria Group, Inc.'>MO</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/BTI' title='British American Tobacco p.l.c. &#40;American Depository Receipts&#41;'>BTI</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/WBC' title='WABCO Holdings Inc.'>WBC</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389739\" data-linked=\"Consumer - Top 5 Gainers / Losers as of 12:00 PM (09/12/2018)\" data-tweet=\"$KBSF $KBSF $REED - Consumer - Top 5 Gainers / Losers as of 12:00 PM (09/12/2018) https://seekingalpha.com/news/3389739-consumer-top-5-gainers-losers-of-12-00-pm-09-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389739-consumer-top-5-gainers-losers-of-12-00-pm-09-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389727\" data-ts=\"1536766232\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPTT\" target=\"_blank\">OPTT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389727-ocean-power-technologies-down-5_4-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocean Power Technologies down 5.4% post Q1 results</a></h4><ul><li>Ocean Power Technologies (<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a> <font color='red'>-5.4%</font>) <a href=\"https://seekingalpha.com/filing/4167916\" target=\"_blank\">reported Q1</a> revenue decrease 85% Y/Y to $0.03M, the decline in revenue is due to the timing of the new contracts signed with Eni and Premier Oil in Q1 2019.</li><li>Net loss was $3.2M.</li><li>Cash, equivalents, restricted cash and marketable securities were $8.4M.</li><li>Net cash used in operating activities was $3.8M.</li><li>The company entered common stock purchase agreement with Aspire Capital Fund.</li><li>Received an important patent to optimize energy harvesting in low to moderate sea states.</li><li>Also, signed contract in June 2018 with Premier Oil to supply a PowerBuoy&trade; for the Huntington Field.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389633-ocean-power-reports-q1-results\" target=\"_blank\">Ocean Power reports Q1 results</a> (Sept. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389727\" data-linked=\"Ocean Power Technologies down 5.4% post Q1 results\" data-tweet=\"$OPTT - Ocean Power Technologies down 5.4% post Q1 results https://seekingalpha.com/news/3389727-ocean-power-technologies-down-5_4-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3389727-ocean-power-technologies-down-5_4-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389728\" data-ts=\"1536766146\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/T\" target=\"_blank\">T</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389728-tplus-2_4-ceo-looks-ahead-to-integration-video-offerings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AT&amp;T +2.4% as CEO looks ahead to integration, video offerings</a></h4><ul>   <li>Speaking at a Goldman Sachs conference, AT&amp;T (<a href='https://seekingalpha.com/symbol/T' title='AT&T Inc.'>T</a> <font color='green'>+2.4%</font>) chief Randall Stephenson says it's full speed ahead on absorbing the former Time Warner into the company, and that he expects <a href=\"https://www.wsj.com/articles/as-it-absorbs-time-warner-at-t-expects-profitability-next-year-1536760417\" target=\"_blank\">better profitability in some divisions</a> next year as the integration proceeds.</li>    <li>Stephenson says he expects a ruling by January or February on the Justice Dept. appeal of its loss in the trial aimed at preventing the merger, which closed in June just two days after the decision.</li>    <li>But integration is <a href=\"https://nypost.com/2018/09/12/att-pressing-ahead-with-time-warner-merger-despite-doj-appeal/\" target=\"_blank\">moving without any hitches</a> and &ldquo;We feel very good where we stand on appeal ... The teams are spending zero effort thinking about the appeal.&rdquo;</li>    <li>Aside from WarnerMedia, Stephenson notes the Mexican business would generate positive EBITDA next year after wrapping a network upgrade, and the Entertainment Group would rebound to flat profits with the help of some price increases. Capex is expected to decline as upgrades play out as well.</li>    <li>And WarnerMedia will launch an <a href=\"https://www.mediaplaynews.com/warnermedia-planning-to-launch-branded-ott-video-service/\" target=\"_blank\">over-the-top video service</a> featuring Warner Bros. and HBO catalog content, with more details to come in Q4.</li>    <li>&ldquo;HBO, we think in terms of SVOD, is a very unique asset,&rdquo; Stephenson says. &ldquo;Netflix (<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a> <font color='green'>+2.2%</font>) is the Walmart of SVOD and HBO is the Tiffany. It is a very premium high-end brand. And Turner is one of the best networks around.&rdquo;</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389728\" data-linked=\"AT&amp;T +2.4% as CEO looks ahead to integration, video offerings\" data-tweet=\"$T $T $NFLX - AT&amp;T +2.4% as CEO looks ahead to integration, video offerings https://seekingalpha.com/news/3389728-tplus-2_4-ceo-looks-ahead-to-integration-video-offerings?source=tweet\" data-url=\"https://seekingalpha.com/news/3389728-tplus-2_4-ceo-looks-ahead-to-integration-video-offerings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389726\" data-ts=\"1536766095\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDXC\" target=\"_blank\">CDXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389726-chromadex-up-15-bargain-hunters-move-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ChromaDex up 15% as bargain hunters move in</a></h4><ul><li>ChromaDex (<a href='https://seekingalpha.com/symbol/CDXC' title='ChromaDex Inc.'>CDXC</a> <font color='green'>+14.9%</font>) is up on modestly higher volume as bargain hunters move in after the recent selloff from the SEC's stock fraud charges against investor Dr. Phillip Frost. Shares had lost ~<font color='red'>22%</font>&nbsp;of their value before today's action.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389336-sec-charges-billionaire-phillip-frost-may-tip-iceberg-barrons\" target=\"_blank\">SEC charges against billionaire Phillip Frost may be 'tip of the iceberg\" - Barron's</a> (Sept. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389726\" data-linked=\"ChromaDex up 15% as bargain hunters move in\" data-tweet=\"$CDXC - ChromaDex up 15% as bargain hunters move in https://seekingalpha.com/news/3389726-chromadex-up-15-bargain-hunters-move-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3389726-chromadex-up-15-bargain-hunters-move-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389725\" data-ts=\"1536765875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTC-USD\" target=\"_blank\">BTC-USD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389725-alts-lead-deepening-crypto-crash\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alts lead deepening crypto crash</a></h4><ul><li>Bitcoin (<a href='https://seekingalpha.com/symbol/BTC-USD' title='Bitcoin USD'>BTC-USD</a>) is roughly flat for the session and remains modestly above its low for the year. At $6,273, it's still about double the level of one year ago. The alts are a different story, and they continue to plunge towards what might be a resting spot of zero for many of them.</li><li>Ether (<a href='https://seekingalpha.com/symbol/ETH-USD' title='Ethereum USD'>ETH-USD</a>) is&nbsp;<font color='red'>down another 7%</font>&nbsp;to $172 - that's off from a high of more than $1,400 earlier in 2018, and roughly flat year-over-year. Litecoin (<a href='https://seekingalpha.com/symbol/LTC-USD' title='Litecoin USD'>LTC-USD</a>) is&nbsp;<font color='red'>lower by 6%</font>&nbsp;to $49. Bitcoin Cash (<a href='https://seekingalpha.com/symbol/BCH-USD' title='Bitcoin Cash USD'>BCH-USD</a>) is&nbsp;<font color='red'>down 4.4%</font>&nbsp;to $420.</li><li>Bloomberg's&nbsp; Michael Patterson <a href=\"https://www.bloomberg.com/news/articles/2018-09-12/crypto-s-crash-just-surpassed-dot-com-levels-as-losses-reach-80?srnd=premium\" target=\"_blank\">notes the crypto crash has</a> hit 80% - that's worse than then 78% plunge in Nasdaq following the bursting of its bubble in 2000. Fortunately for the global economy, the actual dollar amounts in crypto are of far smaller measure than the trillions wiped out in the tech crash.</li><li><a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>&nbsp;<font color='red'>-0.9%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3389725\" data-linked=\"Alts lead deepening crypto crash\" data-tweet=\"$BTC-USD $BTC-USD $ETH-USD - Alts lead deepening crypto crash https://seekingalpha.com/news/3389725-alts-lead-deepening-crypto-crash?source=tweet\" data-url=\"https://seekingalpha.com/news/3389725-alts-lead-deepening-crypto-crash\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389723\" data-ts=\"1536765427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CSOD\" target=\"_blank\">CSOD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389723-cornerstone-ondemand-acquires-hiring-platform-announces-recruiting-solution\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cornerstone OnDemand acquires hiring platform, announces recruiting solution</a></h4><ul><li>        Cornerstone OnDemand (NASDAQ:<a href='https://seekingalpha.com/symbol/CSOD' title='Cornerstone OnDemand, Inc.'>CSOD</a>)<a href=\"https://seekingalpha.com/pr/17267365-cornerstone-unveils-frontline-recruiting-solution-acquisition-workpop\" target=\"_blank\"> announces</a> acquiring hiring platform Workpop for undisclosed terms.</li><li>               As the result of the acquisition, the company unveils Cornerstone Frontline, a recruiting solution for companies wanting to hire local, entry-level and frontline employees.&nbsp;</li><li>               Cornerstone Frontline combines Cornerstone&rsquo;s enterprise applicant tracking system and Workpop&rsquo;s recruiting solution. The product will become available next year as part of the Cornerstone Recruiting suite.&nbsp;</li><li>               Workpop&rsquo;s platform supports smaller retail chains and larger brands like The Peninsula Hotels, Sweetgreen, and Hillstone Restaurant Group.&nbsp;</li><li>                  Cornerstone shares are&nbsp;<font color='red'>down 1.1%</font>&nbsp;to $57.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3389723\" data-linked=\"Cornerstone OnDemand acquires hiring platform, announces recruiting solution\" data-tweet=\"$CSOD - Cornerstone OnDemand acquires hiring platform, announces recruiting solution https://seekingalpha.com/news/3389723-cornerstone-ondemand-acquires-hiring-platform-announces-recruiting-solution?source=tweet\" data-url=\"https://seekingalpha.com/news/3389723-cornerstone-ondemand-acquires-hiring-platform-announces-recruiting-solution\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389722\" data-ts=\"1536765389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XBIT\" target=\"_blank\">XBIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389722-xbiotech-tries-to-right-ship-shares-up-24\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XBiotech tries to right the ship, shares up 24%</a></h4><ul><li>Thinly traded micro cap XBiotech (<a href='https://seekingalpha.com/symbol/XBIT' title='Xbiotech'>XBIT</a> <font color='green'>+23.8%</font>) is up on almost a 5x surge in volume, trying to reverse a nearly&nbsp;<font color='red'>50%</font>&nbsp;selloff since last week.</li><li>This morning, the company <a href=\"https://seekingalpha.com/pr/17267332-xbiotech-announces-addition-world-leading-cardiologist-dr-peter-libby-scientific-advisory\" target=\"_blank\">announced </a>that noted cardiologist Dr. Peter Libby has joined its Scientific Advisory Board. He will help develop its research and clinical programs including evaluating bermekimab's ability to reduce the risk of heart attack or stroke.</li><li>Dr. Libby's group discovered a mechanism behind heart attacks and stroke that may involve inflammation that bermekimab, an inhibitor of the pro-inflammatory cytokine IL-1 alpha, targets.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389722\" data-linked=\"XBiotech tries to right the ship, shares up 24%\" data-tweet=\"$XBIT - XBiotech tries to right the ship, shares up 24% https://seekingalpha.com/news/3389722-xbiotech-tries-to-right-ship-shares-up-24?source=tweet\" data-url=\"https://seekingalpha.com/news/3389722-xbiotech-tries-to-right-ship-shares-up-24\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389718\" data-ts=\"1536764477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NMRD\" target=\"_blank\">NMRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389718-healthcare-top-5-gainers-losers-of-11-00-09-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/12/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NMRD' title='Nemaura Medical, Inc.'>NMRD</a> <font color='green'>+53%</font>. <a href='https://seekingalpha.com/symbol/XBIT' title='Xbiotech'>XBIT</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CDXC' title='ChromaDex Inc.'>CDXC</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/VTL' title='Vital Therapies, Inc.'>VTL</a> <font color='red'>-88%</font>. <a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/VBIV' title='VBI Vaccines'>VBIV</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/VERU' title='Veru Inc.'>VERU</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389718\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/12/2018)\" data-tweet=\"$NMRD $NMRD $XBIT - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (09/12/2018) https://seekingalpha.com/news/3389718-healthcare-top-5-gainers-losers-of-11-00-09-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389718-healthcare-top-5-gainers-losers-of-11-00-09-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389717\" data-ts=\"1536764376\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NMRD\" target=\"_blank\">NMRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389717-nemaura-closing-in-on-u-s-marketing-application-for-cgm-sugarbeat-shares-up-49\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nemaura closing in on U.S. marketing application for CGM sugarBEAT; shares up 49%</a></h4><ul><li>Thinly traded Nemaura Medical (<a href='https://seekingalpha.com/symbol/NMRD' title='Nemaura Medical, Inc.'>NMRD</a> <font color='green'>+49.4%</font>) is up on a whopping 42x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/17267286-nemaura-reports-positive-interim-data-clinic-portion-sugarbeat-fda-clinical-trial\" target=\"_blank\">announcement </a>of interim clinical data on sugarBEAT, its continuous glucose monitoring &#40;CGM&#41; system.</li><li>Data generated from 25 patients with Type 1 and Type 2 diabetes showed a range of results (mean absolute relative deviation or MARD) of 12.19% for the one-point calibration and 10.65% for the two-point calibration, in line with expectations and on par with competitive CGM devices.</li><li>The company expects to launch sugarBEAT in England in the coming months. It plans to file its U.S. marketing application in Q1 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389717\" data-linked=\"Nemaura closing in on U.S. marketing application for CGM sugarBEAT; shares up 49%\" data-tweet=\"$NMRD - Nemaura closing in on U.S. marketing application for CGM sugarBEAT; shares up 49% https://seekingalpha.com/news/3389717-nemaura-closing-in-on-u-s-marketing-application-for-cgm-sugarbeat-shares-up-49?source=tweet\" data-url=\"https://seekingalpha.com/news/3389717-nemaura-closing-in-on-u-s-marketing-application-for-cgm-sugarbeat-shares-up-49\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389712\" data-ts=\"1536763746\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/C\" target=\"_blank\">C</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389712-citigroupplus-2-after-boosting-guidance-on-roe-cost-savings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citigroup +2% after boosting guidance on ROE, cost savings</a></h4><ul>     <li>Citigroup (<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color='green'>+2.1%</font>) enjoys strong gains after CFO John Gerspach said the bank expects to <a href=\"https://www.reuters.com/article/us-usa-banks-conference-citigroup/citigroup-boosts-guidance-to-reflect-improved-tax-outlook-idUSKCN1LS25Z?il=0\" target=\"_blank\">exceed its previous targets</a> for returns on shareholder equity and cost savings.</li>     <li>Citi now expects return on average tangible common shareholders equity of 13.5% by 2020 and 16% long term, up from previous guidance of ~11%, Gerspach tells the Barclays Global Financial Services Conference.</li>     <li>The bank also raises its cost savings estimate by $300M to $2.8B by 2020 and expects a new tax rate of below 24% over time.</li>     <li>The CFO also forecasts Q3 total fixed income and trading revenue to come in flat to slightly higher while investment banking revenue will be slightly lower to reflect volumes and transactions that may close in Q4.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389712\" data-linked=\"Citigroup +2% after boosting guidance on ROE, cost savings\" data-tweet=\"$C - Citigroup +2% after boosting guidance on ROE, cost savings https://seekingalpha.com/news/3389712-citigroupplus-2-after-boosting-guidance-on-roe-cost-savings?source=tweet\" data-url=\"https://seekingalpha.com/news/3389712-citigroupplus-2-after-boosting-guidance-on-roe-cost-savings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389709\" data-ts=\"1536763366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRY\" target=\"_blank\">TLRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389709-citron-reiterates-bearish-view-on-pot-stock-tilray-investors-unmoved-shares-up-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron reiterates bearish view on pot stock Tilray; investors unmoved, shares up 10%</a></h4><ul><li>Investors continue to ignore Citron Research on marijuana producer Tilray (<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color='green'>+10.4%</font>). Shares have rallied&nbsp;<font color='green'>37%</font>&nbsp;since it&nbsp;<a href=\"https://seekingalpha.com/news/3387618-citron-bearish-tilray-due-valuation-shares-9-percent\" target=\"_blank\">announced </a>its bearish view on September 4.</li><li>Citron <a href=\"https://citronresearch.com/our-final-word-on-tlry-before-50/\" target=\"_blank\">believes </a>the stock is headed to $50, ~53% lower than its current price, due to over-valuation. It also mentions that U.S.- listed weed companies are not allowed to have operations here while Canada-listed firms can, a huge asymmetry since the U.S. cannabis market will be the largest in the world.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389709\" data-linked=\"Citron reiterates bearish view on pot stock Tilray; investors unmoved, shares up 10%\" data-tweet=\"$TLRY - Citron reiterates bearish view on pot stock Tilray; investors unmoved, shares up 10% https://seekingalpha.com/news/3389709-citron-reiterates-bearish-view-on-pot-stock-tilray-investors-unmoved-shares-up-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3389709-citron-reiterates-bearish-view-on-pot-stock-tilray-investors-unmoved-shares-up-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389706\" data-ts=\"1536762759\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSC-OLD\" target=\"_blank\">SSC-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389706-ideanomics-launches-financial-info-jv-asia-times\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ideanomics launches financial-info JV with Asia Times</a></h4><ul>   <li>Ideanomics (<a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a> <font color='red'>-3.2%</font>) -- the former Seven Stars Cloud -- has launched a <a href=\"https://seekingalpha.com/pr/17267836-ideanomics-announces-ground-breaking-joint-venture-asia-times-takes-10-percent-ownership\" target=\"_blank\">joint venture with Asia Times</a> to develop a next-generation financial information service.</li>    <li>That arrangement will involve Ideanomics taking a 10% stake in Asia Times Holdings and investing in that company and the JV, to be called Asia Times Financial Ltd.</li>    <li>The JV will offer financial info services via AI-enabled data and analytics it says will be delivered to investors through \"end-to-end encrypted instant messaging services that can work in parallel with blockchain-based financial services.\"</li>    <li>Ideanomics had just announced that Asia Times Holdings Chairman Uwe Parpart was <a href=\"https://seekingalpha.com/news/3389149-ideanomics-names-co-ceo-two-others-executive-suite\" target=\"_blank\">joining the company</a> as chief strategy officer.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389706\" data-linked=\"Ideanomics launches financial-info JV with Asia Times\" data-tweet=\"$SSC-OLD - Ideanomics launches financial-info JV with Asia Times https://seekingalpha.com/news/3389706-ideanomics-launches-financial-info-jv-asia-times?source=tweet\" data-url=\"https://seekingalpha.com/news/3389706-ideanomics-launches-financial-info-jv-asia-times\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389704\" data-ts=\"1536762672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAGX\" target=\"_blank\">JAGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389704-jaguar-health-readies-equity-offering-shares-down-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jaguar Health readies equity offering; shares down 2%</a></h4><ul><li>Thinly traded nano cap Jaguar Health (<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Animal Health, Inc.'>JAGX</a> <font color='red'>-1.6%</font>) slips on average volume on the heels of its preliminary <a href=\"https://www.sec.gov/Archives/edgar/data/1585608/000104746918006150/a2236673zs-1.htm\" target=\"_blank\">prospectus </a>for a public offering of stock and warrants. Price, volume and terms have yet to be released.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389704\" data-linked=\"Jaguar Health readies equity offering; shares down 2%\" data-tweet=\"$JAGX - Jaguar Health readies equity offering; shares down 2% https://seekingalpha.com/news/3389704-jaguar-health-readies-equity-offering-shares-down-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3389704-jaguar-health-readies-equity-offering-shares-down-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389703\" data-ts=\"1536762634\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389703-eia-petroleum-inventories\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Petroleum Inventories</a></h4><ul>     <li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories:</a> Crude <strong>-5.3M</strong> barrels vs. -1.3M consensus, -4.3M last week.</li><li>Gasoline <strong>+1.3M</strong> barrels vs. +1.3M consensus, +1.8M last week.</li><li>Distillates <strong>+6.2M</strong> barrels vs. +1.4M consensus, +3.1M last week.</li><li>Futures&nbsp;<font color='green'>+1.63%</font>&nbsp;to $70.38.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3389703\" data-linked=\"EIA Petroleum Inventories\" data-tweet=\"$USO $OIL $UCO - EIA Petroleum Inventories https://seekingalpha.com/news/3389703-eia-petroleum-inventories?source=tweet\" data-url=\"https://seekingalpha.com/news/3389703-eia-petroleum-inventories\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389693\" data-ts=\"1536761532\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389693-discovery-hulu-strike-multi-year-deal-for-live-and-on-demand-shows\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Discovery, Hulu strike multi-year deal for live and on-demand shows</a></h4><ul>   <li>A comprehensive deal will extend the popular series of Discovery TV (<a href=\"http://seekingalpha.com/symbol/DISCA\" target=\"_blank\">DISCA</a> <font color='green'>+6.8%</font>) to the live and on-demand stores of Hulu.</li>    <li>The multi-year agreement boosts Hulu's inventory of Discovery programming to almost 4,000 episodes, including popular programs like <i>Deadliest Catch, MythBusters, Property Brothers, Chopped, House Hunters</i> and more.</li>    <li>It also adds five more Discovery networks to Hulu's live TV plan, including Discovery Channel, TLC, Investigation Discovery, Motor Trend (the renamed Velocity Network) and Animal Planet; they join HGTV, Food Network and Travel Channel, which had come to Hulu via previous agreement with Scripps Networks.</li>    <li>Also, Hulu reached a licensing deal with OWN to bring four scripted series exclusively to Hulu.</li>    <li>The five live channels will be available for streaming beginning in December.</li>    <li>Hulu is co-owned by Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='red'>-1.1%</font>), Disney (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='red'>-0.1%</font>), Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-0.1%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+0.1%</font>) and WarnerMedia (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='green'>+2.6%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389693\" data-linked=\"Discovery, Hulu strike multi-year deal for live and on-demand shows\" data-tweet=\"$FOX $FOX $FOXA - Discovery, Hulu strike multi-year deal for live and on-demand shows https://seekingalpha.com/news/3389693-discovery-hulu-strike-multi-year-deal-for-live-and-on-demand-shows?source=tweet\" data-url=\"https://seekingalpha.com/news/3389693-discovery-hulu-strike-multi-year-deal-for-live-and-on-demand-shows\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389691\" data-ts=\"1536760953\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DFFN\" target=\"_blank\">DFFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389691-diffusion-pharma-on-go-mid-stage-ambulance-based-study-of-tsc-shares-up-34\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diffusion Pharma on go with mid-stage ambulance-based study of TSC; shares up 34%</a></h4><ul><li>Thinly traded nano cap Diffusion Pharmaceuticals (<a href='https://seekingalpha.com/symbol/DFFN' title='Diffusion Pharmaceuticals Inc.'>DFFN</a> <font color='green'>+34.2%</font>) is up on a 10x surge in volume on the heels of its <a href=\"https://seekingalpha.com/pr/17267683-fda-approves-start-innovative-ambulance-phase-2-clinical-trial-treatment-acute-stroke\" target=\"_blank\">announcement </a>that the FDA has signed off on an ambulance-based Phase 2 clinical trial evaluating lead drug trans sodium crocetinate &#40;TSC&#41; for the front-line treatment of acute stroke.</li><li>The study, called PHAST-TSC, will involve 23 hospitals in Los Angeles, CA and Central Virginia who will work with ~150 emergency medical transport groups. Topline data should be available in ~two years.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389691\" data-linked=\"Diffusion Pharma on go with mid-stage ambulance-based study of TSC; shares up 34%\" data-tweet=\"$DFFN - Diffusion Pharma on go with mid-stage ambulance-based study of TSC; shares up 34% https://seekingalpha.com/news/3389691-diffusion-pharma-on-go-mid-stage-ambulance-based-study-of-tsc-shares-up-34?source=tweet\" data-url=\"https://seekingalpha.com/news/3389691-diffusion-pharma-on-go-mid-stage-ambulance-based-study-of-tsc-shares-up-34\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389690\" data-ts=\"1536760842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONC\" target=\"_blank\">SONC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389690-sonic-rally-seen-oppenheimer-overextended\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonic rally seen by Oppenheimer as overextended</a></h4><ul> <li>Oppenheimer keeps a Perform rating on Sonic (<a href='https://seekingalpha.com/symbol/SONC' title='Sonic Corp.'>SONC</a> <font color='red'>-1.7%</font>) on its view that the risk-reward profile on the restaurant stock is too stretched.</li> <li>The investment firm points to the ~50% share price jump based off a return of the company to positive same-store sales growth.</li> <li>Analyst Brian Bittner: \"We believe recent installment of long-term targets tilts aggressively, particularly assumption for +2-4% SSS. With revision potential to Street EPS estimates now limited, short interest now below-average, and valuation now above 23x P/ E (and below 5% FCF yield), we see risk/reward as unattractive.\"</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3389690\" data-linked=\"Sonic rally seen by Oppenheimer as overextended\" data-tweet=\"$SONC - Sonic rally seen by Oppenheimer as overextended https://seekingalpha.com/news/3389690-sonic-rally-seen-oppenheimer-overextended?source=tweet\" data-url=\"https://seekingalpha.com/news/3389690-sonic-rally-seen-oppenheimer-overextended\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389683\" data-ts=\"1536760469\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLSN\" target=\"_blank\">NLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389683-nielsenplus-5-on-sale-talks-suntrust-boosts-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nielsen +5% on sale talks; SunTrust boosts target</a></h4><ul>   <li>Nielsen Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NLSN' title='Nielsen Holdings N.V.'>NLSN</a>) is <font color='green'>up 5%</font> the morning after a report says the company will bow to pressure from Elliott Management and <a href=\"https://seekingalpha.com/news/3389532-reuters-nielsen-exploring-sale-entire-company\" target=\"_blank\">consider an outright sale</a>.</li>    <li>Previous strategic explorations had Nielsen considering selling its \"Buy\" segment rather than the \"Watch\" segment that encapsulates the media ratings with which the company is synonymous.</li>    <li>SunTrust has raised its price target to $28; \"recent conversations with activists and with private equity firms lead us to believe there is ample liquidity and appetite to pursue transactions,\" says analyst Matthew Thornton. He believes overall readthrough to comScore (SCOR <font color='green'>+0.2%</font>.%) is positive as well. (h/t Bloomberg)</li>    <li><a href='https://seekingalpha.com/symbol/NLSN' title='Nielsen Holdings N.V.'>NLSN</a> has been on the decline this year, <font color='red'>down 27.5%</font> in 2018 after <font color='red'>dropping 16.2%</font> over the past quarter, but has <font color='green'>rebounded 20%</font> in the past month.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389683\" data-linked=\"Nielsen +5% on sale talks; SunTrust boosts target\" data-tweet=\"$NLSN - Nielsen +5% on sale talks; SunTrust boosts target https://seekingalpha.com/news/3389683-nielsenplus-5-on-sale-talks-suntrust-boosts-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3389683-nielsenplus-5-on-sale-talks-suntrust-boosts-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389669\" data-ts=\"1536759054\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBC\" target=\"_blank\">WBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389669-wabco-falls-sharply-after-guidance-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WABCO falls sharply after guidance update</a></h4><ul> <li>WABCO (<a href='https://seekingalpha.com/symbol/WBC' title='WABCO Holdings Inc.'>WBC</a>) provides a guidance update to investors today.</li>   <li>The company says the recent \"intensification of geopolitical dynamics\" is negatively impacting markets and currencies in some of the company's regions.</li><li>WABCO now expects that truck and bus production in China will deteriorate by ~30% in the second half of the year and 11% on a full year basis. WABCO also notes a slowdown in demand from Russia and Turkey.</li>  <li>Due to the economic and political conditions, WABCO expects to end in the lower half of its previously issued EPS guidance for the full year 2018. The company aims to partially mitigate the effect of these market factors through cost management activities.</li><li>Shares of WABCO&nbsp;opened&nbsp;<font color='red'>down 9%</font>&nbsp;in initial trades.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17267085-wabco-provides-update-within-2018-eps-guidance-range-reflecting-impact-fast-evolving\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3389669\" data-linked=\"WABCO falls sharply after guidance update\" data-tweet=\"$WBC - WABCO falls sharply after guidance update https://seekingalpha.com/news/3389669-wabco-falls-sharply-after-guidance-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3389669-wabco-falls-sharply-after-guidance-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389668\" data-ts=\"1536759011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRTX\" target=\"_blank\">HRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389668-heron-therapeutics-down-4-premarket-ahead-of-block-trade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Heron Therapeutics down 4% premarket ahead of block trade</a></h4><ul><li>Heron Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/HRTX' title='Heron Therapeutics, Inc.'>HRTX</a>) slips&nbsp;<font color='red'>4%</font>&nbsp;premarket on light volume following the pricing for a planned block trade at the open.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389668\" data-linked=\"Heron Therapeutics down 4% premarket ahead of block trade\" data-tweet=\"$HRTX - Heron Therapeutics down 4% premarket ahead of block trade https://seekingalpha.com/news/3389668-heron-therapeutics-down-4-premarket-ahead-of-block-trade?source=tweet\" data-url=\"https://seekingalpha.com/news/3389668-heron-therapeutics-down-4-premarket-ahead-of-block-trade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389663\" data-ts=\"1536758702\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXIM\" target=\"_blank\">MXIM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389663-stifel-downgrades-semis-on-signs-of-peak\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stifel downgrades semis on signs of peak</a></h4><ul><li>        Stifel downgrades Maxim Integrated Products (NASDAQ:<a href='https://seekingalpha.com/symbol/MXIM' title='Maxim Integrated Products, Inc.'>MXIM</a>) from Buy to Hold and cuts its target by $10 to $65, an 8% upside to yesterday&rsquo;s close.</li><li>               The firm cites the peaking semiconductor cycle and rising interest rates with a side of tariff-related uncertainties.&nbsp;</li><li>               Stifel also downgraded NXP Semiconductors, cut Macom (NASDAQ:<a href='https://seekingalpha.com/symbol/MTSI' title='MACOM Technology Solutions Holdings, Inc.'>MTSI</a>) from Hold to Sell with the target dropping $2 to $20, and dropped Power Integrations (NASDAQ:<a href='https://seekingalpha.com/symbol/POWI' title='Power Integrations, Inc.'>POWI</a>) from Buy to Hold with a $10 target reduction to $75.&nbsp;</li><li>               Maxim shares are&nbsp;<font color='red'>down 2.2%&nbsp;</font>premarket to $58.70. &nbsp;&nbsp;</li><li>                  Macom shares are flat at $21.98 and Power Integrations is inactive at $70.15.&nbsp;&nbsp;&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3389653-nxp-drops-stifel-downgrade-exec-strategy-outline\" target=\"_blank\">NXP drops on Stifel downgrade, exec strategy outline</a> (Sept. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389663\" data-linked=\"Stifel downgrades semis on signs of peak\" data-tweet=\"$MXIM $MXIM $MTSI - Stifel downgrades semis on signs of peak https://seekingalpha.com/news/3389663-stifel-downgrades-semis-on-signs-of-peak?source=tweet\" data-url=\"https://seekingalpha.com/news/3389663-stifel-downgrades-semis-on-signs-of-peak\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389660\" data-ts=\"1536758436\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389660-pandoraplus-1_7-needham-sets-street-high-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora +1.7% as Needham sets Street-high target</a></h4><ul>   <li>Pandora Media (NYSE:<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a>) is <font color='green'>up 1.7%</font> after getting a new Street-high price target at Needham.</li>    <li>Analyst Laura Martin has boosted her target to $13 from $8, implying 38% upside, on prospects for faster sub growth from a focus on partnerships, and lower customer acquisition costs. Minimum CPM prices per ad unit will shake out the ones with the lowest profitability, she says, and the company will execute better in other ways, including cost efficiencies. (h/t Bloomberg)</li>    <li>Pandora shares are <font color='green'>up 18.9%</font> over the past month and have <font color='green'>risen 96%</font> in 2018.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389660\" data-linked=\"Pandora +1.7% as Needham sets Street-high target\" data-tweet=\"$P - Pandora +1.7% as Needham sets Street-high target https://seekingalpha.com/news/3389660-pandoraplus-1_7-needham-sets-street-high-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3389660-pandoraplus-1_7-needham-sets-street-high-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389658\" data-ts=\"1536758236\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABEO\" target=\"_blank\">ABEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389658-abeona-on-go-gene-therapy-study-in-mps-iiib-in-spain-shares-up-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abeona on go with gene therapy study in MPS IIIB in Spain; shares up 1% premarket</a></h4><ul><li>Abeona Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a>) is up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17267533-abeona-therapeutics-announces-authorization-commence-phase-1-2-gene-therapy-clinical-study\" target=\"_blank\">announcement </a>that authorities in Spain have signed off on the start of a Phase 1/2 clinical trial evaluating gene therapy ABO-101 in patients with MPS IIIB or <a href=\"https://rarediseases.info.nih.gov/diseases/7072/mucopolysaccharidosis-type-iiib\" target=\"_blank\">Sanfilippo syndrome type B</a>, an inherited disorder in which the body is unable to break down large sugar molecules called glycosaminoglycans (GAGs).</li><li>The study will be conducted at a single hospital there. The company plans to add sites in France, Germany and England (U.S. sites have already been initiated).</li><li>ABO-101 has Orphan Drug status for the indication in the U.S. and EU and Rare Pediatric Disease Designation in the U.S.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389658\" data-linked=\"Abeona on go with gene therapy study in MPS IIIB in Spain; shares up 1% premarket\" data-tweet=\"$ABEO - Abeona on go with gene therapy study in MPS IIIB in Spain; shares up 1% premarket https://seekingalpha.com/news/3389658-abeona-on-go-gene-therapy-study-in-mps-iiib-in-spain-shares-up-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3389658-abeona-on-go-gene-therapy-study-in-mps-iiib-in-spain-shares-up-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389657\" data-ts=\"1536758231\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOMX\" target=\"_blank\">FOMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389657-premarket-gainers-of-9-05-09-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (09/12/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/FOMX' title='Foamix Pharmaceuticals'>FOMX</a> <font color='green'>+31%</font>&nbsp;as acne drug <a href=\"https://seekingalpha.com/news/3389526-foamix-pharma-plus-54-percent-acne-drug-meets-goals-late-stage-trial\" target=\"_blank\">meets goals</a> in late-stage trial.</li><li><a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a> <font color='green'>+17%</font>&nbsp;on filgotinib <a href=\"https://seekingalpha.com/news/3389481-gileads-filgotinib-successful-late-stage-study-treatment-resistant-rheumatoid-arthritis\" target=\"_blank\">successful</a> in late-stage study in treatment-resistant rheumatoid arthritis.</li><li><a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a> <font color='green'>+11%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3389603-bausch-health-resolves-xifaxan-patent-dispute-actavis\" target=\"_blank\">resolving</a> Xifaxan patent dispute with Actavis.</li><li><a href='https://seekingalpha.com/symbol/AKTX' title='Akari Therapeutics Plc'>AKTX</a> <font color='green'>+7%</font>&nbsp;as FDA <a href=\"https://seekingalpha.com/news/3384044-fda-accepts-priority-review-alxn1210-treatment-patients-pnh-us\" target=\"_blank\">accepts</a> priority review of ALXN1210 as a treatment for patients with PNH in the US.</li><li><a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color='green'>+7%</font>&nbsp;continues it <a href=\"https://seekingalpha.com/pr/17266059-tilray-exports-2-100-cbd-oil-united-kingdom\" target=\"_blank\">run</a>.</li><li><a href='https://seekingalpha.com/symbol/SLCA' title='U.S. Silica'>SLCA</a> <font color='green'>+6%</font>&nbsp;on&nbsp;long-term sand supply <a href=\"https://seekingalpha.com/news/3389496-pioneer-natural-resources-u-s-silica-unveil-long-term-sand-supply-deal\" target=\"_blank\">deal</a>.</li><li><a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics, Inc.'>ATOS</a> <font color='green'>+5%</font>&nbsp;on conference call tomorrow on <a href=\"https://seekingalpha.com/news/3389626-atossa-conference-call-tomorrow-phase-1-results-topical-endoxifen-shares-10-percent-premarket\" target=\"_blank\">Phase 1 results</a> for topical endoxifen.</li><li><a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='green'>+5%</font>&nbsp;as&nbsp;Q3 <a href=\"https://seekingalpha.com/news/3389622-northern-oil-and-gas-says-q3-production-tracking-significantly-guidance\" target=\"_blank\">production</a> tracking significantly above guidance.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389657\" data-linked=\"Premarket Gainers as of 9:05 am (09/12/2018)\" data-tweet=\"$FOMX $FOMX $GLPG - Premarket Gainers as of 9:05 am (09/12/2018) https://seekingalpha.com/news/3389657-premarket-gainers-of-9-05-09-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389657-premarket-gainers-of-9-05-09-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389653\" data-ts=\"1536757867\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NXPI\" target=\"_blank\">NXPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389653-nxp-drops-on-stifel-downgrade-exec-strategy-outline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NXP drops on Stifel downgrade, exec strategy outline</a></h4><ul><li>        Stifel downgrades NXP Semiconductors (NASDAQ:<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a>) from Hold to Sell and cuts its target from $99 to $84.</li><li>               The firm says the previously announced &ldquo;massive&rdquo; buyback will greatly cut share count and enhance both EPS and FCF/share, but going &ldquo;deeply into debt&rdquo; risks the company profile in a peaking semi market. (Source: Bloomberg First Word.)&nbsp;</li><li>               After hours yesterday, NXP <a href=\"https://www.reuters.com/article/us-nxp-semicondtrs-investors/nxp-shares-drop-after-executives-outline-post-qualcomm-path-idUSKCN1LR2NU\" target=\"_blank\">execs</a> outlined their strategy following the collapse of the proposed Qualcomm merger.&nbsp;</li><li>               NXP wants to grow sales 5% to 7% per year between now and the end of 2021, about 50% more than the estimated growth rate for the chip industry.&nbsp;</li><li>               The company wants to boost gross margins from the current 53% to 55% range by the end of next year to as much as 57% by the 2021 deadline, which could involve selling off slow or low-margin businesses.&nbsp;</li><li>               NXP shares are<font color='red'> down 1%&nbsp;</font>premarket to $88.70. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3374093-nxp-semi-minus-8_5-percent-q2-results-qualcomm-end-5b-repurchase-program\" target=\"_blank\">NXP Semi -8.5% on Q2 results, Qualcomm end, $5B repurchase program</a> (July 26)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3374750-china-comments-scrapped-qualcomm-nxp-takeover\" target=\"_blank\">China comments on scrapped Qualcomm-NXP takeover</a> (July 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389653\" data-linked=\"NXP drops on Stifel downgrade, exec strategy outline\" data-tweet=\"$NXPI - NXP drops on Stifel downgrade, exec strategy outline https://seekingalpha.com/news/3389653-nxp-drops-on-stifel-downgrade-exec-strategy-outline?source=tweet\" data-url=\"https://seekingalpha.com/news/3389653-nxp-drops-on-stifel-downgrade-exec-strategy-outline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389652\" data-ts=\"1536757750\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTL\" target=\"_blank\">VTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389652-premarket-losers-of-9-05-9-12-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (9/12/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/VTL' title='Vital Therapies, Inc.'>VTL</a>&nbsp;<font color='red'>-89%</font>&nbsp;as VTL-308 <a href=\"https://seekingalpha.com/news/3389563-vital-therapies-82-percent-vtlminus-308-fails-achieve-primary-secondary-endpoints-improvement\" target=\"_blank\">fails</a> to achieve primary and secondary endpoints of improvement in survival.</li><li>COOL&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3389595-polarityte-reports-q3-results\" target=\"_blank\">Q3 result</a>.</li><li><a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a> <font color='red'>-8%</font>.</li><li><a href='https://seekingalpha.com/symbol/GMED' title='Globus Medical'>GMED</a> <font color='red'>-6%</font>.</li><li><a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>&nbsp;<font color='red'>-6%</font>&nbsp;on BTIG <a href=\"https://seekingalpha.com/news/3389590-snap-drops-btig-downgrade-50-percent-downside\" target=\"_blank\">downgrade</a> with 50% downside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389652\" data-linked=\"Premarket Losers as of 9:05 am (9/12/2018)\" data-tweet=\"$VTL $IMUX $PTE - Premarket Losers as of 9:05 am (9/12/2018) https://seekingalpha.com/news/3389652-premarket-losers-of-9-05-9-12-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3389652-premarket-losers-of-9-05-9-12-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389651\" data-ts=\"1536757740\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IDEXY\" target=\"_blank\">IDEXY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389651-inditex-impresses-first-half-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inditex impresses with first half results</a></h4><ul> <li>Inditex (<a href='https://seekingalpha.com/symbol/IDEXY' title='Industria de Diseno Textil Inditex SA ADR'>OTCPK:IDEXY</a>) reports comparable sales growth of 4% during the first half of the year and forecasts a 4% to 6% comp for the second half of the year.</li> <li>While the Zara parent's pace of comparable sales fell back from prior levels, the company is still topping peers this year. The ship-from-stores initiative at Inditex may be accounting for the market share grab.</li> <li>Inditex churned up totals sales growth of 3% to &euro;12B during 1H and net profit growth of 3% to &euro;1.4B</li> <li><a href=\"https://www.inditex.com/en/article?articleId=599096&amp;title=Inditex+net+sales+climb+3%25+in+the+%EF%AC%81rst+six+months%2C+8%25+in+local+currencies\" target=\"_blank\">Inditex press release</a></li> <li>Shares of Inditex are <font color='green'>up 3.3%</font> in Madrid trading.</li> <li>Related stocks: <a href='https://seekingalpha.com/symbol/HNNMY' title='Hennes & Mauritz AB ADR'>OTCPK:HNNMY</a>, <a href='https://seekingalpha.com/symbol/HMRZF' title='Hennes & Mauritz ABB'>OTCPK:HMRZF</a>, <a href='https://seekingalpha.com/symbol/FRCOY' title='Fast Retailing Co. Ltd. ADR'>OTCPK:FRCOY</a>, <a href='https://seekingalpha.com/symbol/LVMHF' title='LVMH-Moet Hennessy Louis Vuitton'>OTCPK:LVMHF</a>, <a href='https://seekingalpha.com/symbol/HESAF' title='Hermes International SA'>OTCPK:HESAF</a>, <a href='https://seekingalpha.com/symbol/PPRUF' title='Kering SA'>OTCPK:PPRUF</a>, <a href='https://seekingalpha.com/symbol/LVMUY' title='LVMH-Moet Hennessy Louis Vuitton ADR'>OTCPK:LVMUY</a>, <a href='https://seekingalpha.com/symbol/CFRHF' title='Compagnie Financiere Richemont AG'>OTCPK:CFRHF</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389651\" data-linked=\"Inditex impresses with first half results\" data-tweet=\"$IDEXY $IDEXY $HNNMY - Inditex impresses with first half results https://seekingalpha.com/news/3389651-inditex-impresses-first-half-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3389651-inditex-impresses-first-half-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389650\" data-ts=\"1536757579\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COCP\" target=\"_blank\">COCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389650-cocrystal-pharma-down-22-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cocrystal Pharma down 22% premarket</a></h4><ul><li>Thinly traded nano cap Cocrystal Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/COCP' title='Cocrystal Pharma, Inc.'>COCP</a>) is poised to continue its SEC charges-stoked decline. Shares are down&nbsp;<font color='red'>22%</font>&nbsp;premarket, albeit on only 125 shares.</li><li>The stock had dropped&nbsp;<font color='red'>13%</font>&nbsp;since September 6 in the wake of SEC charges of stock fraud against board member Dr. Phillip Frost and others.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3389336-sec-charges-billionaire-phillip-frost-may-tip-iceberg-barrons\" target=\"_blank\">SEC charges against billionaire Phillip Frost may be 'tip of the iceberg\" - Barron's</a> (Sept. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389650\" data-linked=\"Cocrystal Pharma down 22% premarket\" data-tweet=\"$COCP - Cocrystal Pharma down 22% premarket https://seekingalpha.com/news/3389650-cocrystal-pharma-down-22-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3389650-cocrystal-pharma-down-22-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389642\" data-ts=\"1536756994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389642-gilead-teams-up-precision-biosciences-in-hbv\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilead teams up with Precision BioSciences in HBV</a></h4><ul><li>Gilead Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>) will <a href=\"https://seekingalpha.com/pr/17267483-gilead-sciences-precision-biosciences-announce-collaboration-develop-therapies-hepatitis-b\" target=\"_blank\">collaborate </a>with privately held <a href=\"http://precisionbiosciences.com/\" target=\"_blank\">Precision BioSciences</a> to develop treatments aimed at eliminating hepatitis B virus &#40;HBV&#41; leveraging Precision's gene editing platform <a href=\"http://precisionbiosciences.com/our-approach/arcus-genome-editing/\" target=\"_blank\">ARCUS</a>.</li><li>Under the terms of the partnership, Precision will be primarily responsible for the development, formulation and preclinical study of the investigational nucleases. Gilead will be responsible for clinical development and commercialization. Precision will be eligible to receive up to $445M in milestones and tiered royalties up to the mid-teens.</li><li>GILD is up&nbsp;<font color='green'>4%</font>&nbsp;premarket on positive Phase 3 results for filgotinib that were announced yesterday after the close.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389642\" data-linked=\"Gilead teams up with Precision BioSciences in HBV\" data-tweet=\"$GILD - Gilead teams up with Precision BioSciences in HBV https://seekingalpha.com/news/3389642-gilead-teams-up-precision-biosciences-in-hbv?source=tweet\" data-url=\"https://seekingalpha.com/news/3389642-gilead-teams-up-precision-biosciences-in-hbv\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389641\" data-ts=\"1536756780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389641-micronminus-4_6-goldman-steps-to-sidelines-on-memory-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron -4.6% as Goldman steps to sidelines on memory concerns</a></h4><ul><li>        Goldman Sachs <a href=\"https://www.cnbc.com/2018/09/12/micron-tumbles-after-goldman-downgrades.html?__source=twitter%7Cmain\" target=\"_blank\">downgrades</a> Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) from Buy to Neutral, joining the warnings about falling memory chip prices.</li><li>               Analyst Mark Delaney cites &ldquo;incremental weakness in both DRAM and NAND fundamentals&rdquo; based on conversations with industry contacts and the firm&rsquo;s supply/demand analysis.&nbsp;</li><li>               Delaney: &ldquo;Memory downturns usually last for several quarters and can see an acceleration in price declines, as customers delay procurement to wait for lower prices when possible, causing a snowballing effect that can lead downturns to be worse than initially anticipated by investors.&rdquo;&nbsp;</li><li>               Micron&nbsp;<font color='red'>drops 4.6%</font>&nbsp;premarket to $41.59.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3389641\" data-linked=\"Micron -4.6% as Goldman steps to sidelines on memory concerns\" data-tweet=\"$MU - Micron -4.6% as Goldman steps to sidelines on memory concerns https://seekingalpha.com/news/3389641-micronminus-4_6-goldman-steps-to-sidelines-on-memory-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3389641-micronminus-4_6-goldman-steps-to-sidelines-on-memory-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>286&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389632\" data-ts=\"1536755655\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZEAL\" target=\"_blank\">ZEAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389632-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Zealand Pharma A/S (NASDAQ:<a href='https://seekingalpha.com/symbol/ZEAL' title='Zealand Pharma'>ZEAL</a>) resumed with Overweight rating at Morgan Stanley following its $205M deal with Royalty Pharma.</li><li>Intercept Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a>) initiated with Buy rating and $192 (68% upside) price target at ROTH Capital.</li><li>Vital Therapies (NASDAQ:<a href='https://seekingalpha.com/symbol/VTL' title='Vital Therapies, Inc.'>VTL</a>) downgraded to Market Perform at William Blair following its ELAD flop. Shares are down&nbsp;<font color='red'>89%</font>&nbsp;premarket on robust volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389632\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$ZEAL $ZEAL $ICPT - Premarket analyst action - healthcare https://seekingalpha.com/news/3389632-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3389632-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:34 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389627\" data-ts=\"1536755349\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCN\" target=\"_blank\">NVCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389627-neovasc-up-9-on-announcing-amendments-to-outstanding-convertible-notes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neovasc up 9% on announcing amendments to outstanding convertible notes</a></h4><ul> <li>Neovasc (NASDAQ:<a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a>) <a href=\"https://seekingalpha.com/pr/17267196-neovasc-announces-amendments-outstanding-convertible-notes-including-1-year-extension-note\" target=\"_blank\">announces</a> that the holders of its senior secured convertible notes have agreed to amend certain terms of the Notes and other concessions.</li>     <li>The Company has entered into a Waiver Agreement applicable to the Holders of all of the Notes, pursuant to which (1) the maturity date of the Notes is extended by one year from May 17, 2019 until May 17, 2020, (2) the Company's permitted quarterly Cash Burn is increased for certain future periods, (3) certain asset allowances applicable to the Company's subsidiaries are increased, and (4) issuances of the Company's common shares will qualify as Excluded Securities and not a Dilutive Issuance.</li> <li>Concurrent with the Waiver Agreement, the Company entered into Lockup and Leak-Out Agreements subject to which the Holders have agreed (1) not to sell Common Shares during the 5 consecutive trading days preceding and 15 consecutive trading days following execution of the Company's planned reverse stock split and (2) that on any trading day from the expiration of the Lockup until November 30, they will not sell Common Shares in an amount exceeding 15% of the daily average volume.</li><li>Shares are up&nbsp;<font color='green'>9%</font>&nbsp;premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3389627\" data-linked=\"Neovasc up 9% on announcing amendments to outstanding convertible notes\" data-tweet=\"$NVCN - Neovasc up 9% on announcing amendments to outstanding convertible notes https://seekingalpha.com/news/3389627-neovasc-up-9-on-announcing-amendments-to-outstanding-convertible-notes?source=tweet\" data-url=\"https://seekingalpha.com/news/3389627-neovasc-up-9-on-announcing-amendments-to-outstanding-convertible-notes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389626\" data-ts=\"1536755219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATOS\" target=\"_blank\">ATOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389626-atossa-conference-call-tomorrow-on-phase-1-results-for-topical-endoxifen-shares-up-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atossa conference call tomorrow on Phase 1 results for topical endoxifen; shares up 10% premarket</a></h4><ul><li>Thinly traded nano cap Atossa Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics, Inc.'>ATOS</a>) is up&nbsp;<font color='green'>10%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17267318-atossa-genetics-host-conference-call-announce-preliminary-results-male-phase-1-study-topical\" target=\"_blank\">announcement </a>that it will host a conference call tomorrow, September 13, at 10:00 am ET to discuss preliminary results from a Phase 1 dose-escalation study of topical endoxifen for the treatment of men with gynecomastia (breast enlargement) due to a hormone imbalance (more estrogen than testosterone).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3365172-atossa-12-percent-advancement-early-stage-study-endoxifen\" target=\"_blank\">Atossa up 12% on advancement of early-stage study of Endoxifen</a> (June 20)</li></ul><div class=\"tiny-share-widget\" data-id=\"3389626\" data-linked=\"Atossa conference call tomorrow on Phase 1 results for topical endoxifen; shares up 10% premarket\" data-tweet=\"$ATOS - Atossa conference call tomorrow on Phase 1 results for topical endoxifen; shares up 10% premarket https://seekingalpha.com/news/3389626-atossa-conference-call-tomorrow-on-phase-1-results-for-topical-endoxifen-shares-up-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3389626-atossa-conference-call-tomorrow-on-phase-1-results-for-topical-endoxifen-shares-up-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389625\" data-ts=\"1536755103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDX\" target=\"_blank\">FDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389625-fedex-hitting-ground-in-u-s-six-days-week\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FedEx hitting the ground in U.S. six days a week</a></h4><ul> <li>FedEx (NYSE:<a href='https://seekingalpha.com/symbol/FDX' title='FedEx Corporation'>FDX</a>) says it will boost ground operations in the U.S. to six days a week all year.</li><li>The company says the expansion is in response to the growing e-commerce demand and record influx of volume       expected this holiday season and beyond.</li>     <li>\"The rise in demand for e-commerce goes beyond peak. It&rsquo;s a year-round       phenomenon and we are ready to meet that demand,\" says FedEx exec&nbsp;Raj Subramaniam.</li><li>FedEx notes that it's prepared for the expansion after making significant facility and automation investments over the last several years.</li><li>FDX  <font color='red'>-0.62%</font> premarket to  $247.71. The 52-week for shares is $274.66.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17267373-fedex-ground-expands-u-s-operations-six-days-per-week-year-round\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3389625\" data-linked=\"FedEx hitting the ground in U.S. six days a week\" data-tweet=\"$FDX - FedEx hitting the ground in U.S. six days a week https://seekingalpha.com/news/3389625-fedex-hitting-ground-in-u-s-six-days-week?source=tweet\" data-url=\"https://seekingalpha.com/news/3389625-fedex-hitting-ground-in-u-s-six-days-week\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389622\" data-ts=\"1536754697\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOG\" target=\"_blank\">NOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389622-northern-oil-gas-says-q3-production-tracking-significantly-above-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northern Oil &amp; Gas says Q3 production tracking significantly above guidance</a></h4><ul>     <li>Northern Oil and Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a>) <font color='green'>+5%</font> pre-market after announced that  preliminary production for July and August topped 25K boe/day, <a href=\"https://seekingalpha.com/pr/17267088-northern-oil-gas-inc-third-quarter-production-tracking-significantly-guidance\" target=\"_blank\">substantially ahead of prior Q3 guidance</a> of 23K-24K boe/day.</li>     <li>NOG says the results do not include pending acquisitions from Pivotal Petroleum Partners and W Energy Partners, both of which are expected to close on schedule.</li>     <li>\"Our core acreage position and execution on the ground continues to provide some of the best wells we have ever seen in the Williston Basin,\" says CEO Brandon Elliott.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389622\" data-linked=\"Northern Oil &amp; Gas says Q3 production tracking significantly above guidance\" data-tweet=\"$NOG - Northern Oil &amp; Gas says Q3 production tracking significantly above guidance https://seekingalpha.com/news/3389622-northern-oil-gas-says-q3-production-tracking-significantly-above-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3389622-northern-oil-gas-says-q3-production-tracking-significantly-above-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389616\" data-ts=\"1536753999\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELF\" target=\"_blank\">ELF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389616-marathon-to-pressure-e-l-f-beauty-for-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marathon to pressure e.l.f. Beauty for sale</a></h4><ul> <li>Activist investor Marathon Partners Equity Management is planning to <a href=\"https://www.wsj.com/articles/activist-marathon-partners-pushes-e-l-f-beauty-to-sell-itself-or-cut-costs-1536707100\" target=\"_blank\">pressure</a> e.l.f. Beauty (NYSE:<a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a>) to sell itself or refocus on core operations in a cost-cutting move, reports <em>The Wall Street Journal</em>.</li><li>Marathon believes e.l.f's branded cosmetics business could attract potential buyers, although it warns that private equity firm TPG holds too much influence on the board ahead of any sales process.</li> <li>Marathon holds a stake of 8.5% in ELF.</li> <li>Shares of e.l.f. Beauty are inactive in the premarket session.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389616\" data-linked=\"Marathon to pressure e.l.f. Beauty for sale\" data-tweet=\"$ELF - Marathon to pressure e.l.f. Beauty for sale https://seekingalpha.com/news/3389616-marathon-to-pressure-e-l-f-beauty-for-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3389616-marathon-to-pressure-e-l-f-beauty-for-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389609\" data-ts=\"1536753540\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCE-OLD\" target=\"_blank\">CCE-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389609-coca-cola-european-partnersplus-4-after-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coca-Cola European Partners +4% after update</a></h4><ul> <li>Coca-Cola European Partners (NYSE:<a href='https://seekingalpha.com/symbol/CCE-OLD' title='Coca-Cola European Partners plc'>CCE-OLD</a>) <a href=\"https://seekingalpha.com/pr/17267075-coca-cola-european-partners-ccep-capital-markets-day-12-september-2018\" target=\"_blank\">lifts</a> its forecast for 2018 earnings per share growth to 7% to 8% from a prior range of 5% to 6%.</li> <li>The company says it plans to repurchase &euro;1.5B worth of shares in New York and Amsterdam, with &euro;500M worth of buybacks scheduled for this year.</li> <li>The Q4 dividend payout ratio is also lifted by the multinational bottler to 50% from 45%.</li> <li>\"We have a realistic and exciting long-term view of the growth opportunity in our markets, having mapped out a vision for the next ten years,\" says CEO Damian Gammell.</li> <li>Shares of CCE are <font color='green'>up 3.74%</font> in premarket trading to $44.90.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3389609\" data-linked=\"Coca-Cola European Partners +4% after update\" data-tweet=\"$CCE-OLD $CCEP - Coca-Cola European Partners +4% after update https://seekingalpha.com/news/3389609-coca-cola-european-partnersplus-4-after-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3389609-coca-cola-european-partnersplus-4-after-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3389602\" data-ts=\"1536752578\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYPT\" target=\"_blank\">EYPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3389602-eyepoint-pharmaceuticals-up-8-on-q4-reults\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EyePoint Pharmaceuticals up 8% on Q4 reults</a></h4><ul><li>EyePoint Pharmaceuticals (<a href='https://seekingalpha.com/symbol/EYPT' title='EyePoint Pharmaceuticals, Inc.'>EYPT</a>) <a href=\"https://seekingalpha.com/pr/17267061-eyepoint-pharmaceuticals-reports-fiscal-2018-fourth-quarter-and-full-year-financial-results\" target=\"_blank\">Q4 results</a>: Revenues: $0.72M (+2.9%); Collaborative R&amp;D: $0.2M (-60.0%); Royalty income: $0.5M (+150.0%).</li><li>Net Loss: ($34.4M); Loss Per Share: ($0.62); Quick Assets: $38.8M (+129.6%).</li><li>YUTIQ PDUFA date is November 5.</li><li>Commercial preparations underway for launch of DEXYCU in H1 2019.</li><li>Shares are up&nbsp;<font color='green'>8%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3389602\" data-linked=\"EyePoint Pharmaceuticals up 8% on Q4 reults\" data-tweet=\"$EYPT - EyePoint Pharmaceuticals up 8% on Q4 reults https://seekingalpha.com/news/3389602-eyepoint-pharmaceuticals-up-8-on-q4-reults?source=tweet\" data-url=\"https://seekingalpha.com/news/3389602-eyepoint-pharmaceuticals-up-8-on-q4-reults\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}